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Despite numerous advances in the field’s understanding of the development and 
maintenance of posttraumatic stress disorder (PTSD), current treatments are often limited 
in effectiveness due to a narrow focus on symptom reduction (Cloitre, 2015; Yehuda et 
al., 2015). One reason for this issue is that the impact of PTSD extends into areas such as 
interpersonal relationships, pursuit of valued activities, and acceptance of the self 
(Cloitre, 2015). These processes appear to be especially relevant in chronic/complex 
PTSD, which is rarely represented in controlled trials (Cloitre, Miranda, Stovall-
McClough, & Han, 2005). As such, PTSD research with an expanded focus beyond 
symptom reduction, especially research conducted in clinical settings, is likely to be 
especially relevant to both PTSD researchers and clinicians working in the field. To that 
end, this study examined the impact of change in self-compassion, psychological 
inflexibility, and interpersonal courage on PTSD symptom reduction, trauma-related 
shame, quality of life, and valued living in an exposure-based PTSD partial 
hospitalization program (n = 537; 75% White; 83% Female; mean age = 36). Latent 
growth curves, including intercepts and slopes (linear, quadratic, cubic, and spline), were 
estimated for all variables under study. All measures except for interpersonal courage 
showed clinically meaningful change over the course of the program. At p < .001, latent 
regressions showed that only admission psychological inflexibility scores predicted 
discharge PTSD symptoms and that only admission interpersonal courage (p = .032) was 
related to discharge quality of life. For the latent growth curves, three-piece spline 
models were retained for PTSD symptoms, self-compassion, and valued living. Linear 
models were retained for psychological inflexibility, quality of life, interpersonal 
courage, and trauma-related shame. For the three PTSD slopes and three valued living 
slopes, only the three self-compassion slopes were significant predictors (p < .001). The 
psychological inflexibility slope predicted both the quality of life slope (p < .001), while 
the interpersonal courage slope predicted the trauma-related shame slope (p < .001). 
Results demonstrate that focusing on processes such as psychological inflexibility, self-
compassion, and interpersonal courage might increase the efficacy of PTSD treatment in 
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The Impact of Change in Self-Compassion, Psychological Flexibility, and 




The study and treatment of posttraumatic stress disorder (PTSD) is a complex and 
ever-evolving topic. While the diagnosis of PTSD originated only 39 years ago in the 
third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III), 
human beings have dealt with the impact of experiencing extremely stressful, traumatic 
events throughout history (Pomerantz, 2017). In fact, the experience and threat of trauma 
has played an important role in human evolution, affecting the sympathetic nervous 
system and related defense strategies (e.g., avoidance, attentive immobility, aggressive 
defense, appeasement; Gilbert, 2010).  
Historically, symptom clusters now contained under the PTSD diagnostic 
umbrella went by many names. Terms like soldier’s heart, war neurosis, shell shock, and 
battle fatigue were all common during various historical periods, though conceptually 
they all shared the assumption that experiencing psychological and physiological distress 
in response to extreme stress was due to an innate characterological weakness 
(Pomerantz, 2017). In the years leading up to the publication of the DSM-III, researchers 
began to challenge this assumption, and with the creation of the PTSD diagnosis, focus 
shifted to the traumatic event as the etiological basis for subsequent symptoms (Keane, 
Wolfe, & Taylor, 1987). Within this diagnostic framework, the first criterion for a PTSD 
diagnosis was clinician assessment of whether a client experienced one of several events 
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that were determined to be traumatic by the authors of the DSM (e.g., war, natural 
disasters, sexual assault; Pomerantz, 2017).   
 Since 1980, there has been a large shift away from experts’ definitions of what is 
“traumatic” to a focus on clinician assessment of whether an individual experienced, 
witnessed, or learned about real or threatened danger stemming from an event 
(Pomerantz, 2017). Because of the inclusion of threatened danger into the DSM-IV 
diagnostic criteria, it is now accepted that a person’s subjective experience of a 
potentially traumatic event is a major determinant of the development of PTSD-related 
symptoms (Creamer, McFarlane, & Burgess, 2005). As a result, in trauma-focused 
treatments, the subjective experience of a traumatic event is placed at the core of the 
cognitive and emotional processing (Powers, Halpern, Ferenschak, Gillihan, & Foa, 
2010). Over the past 39 years, research has allowed for more targeted treatments by 
including anhedonic and dysphoric symptom clusters under the PTSD diagnostic 
umbrella, as well as unique presentations related to one’s culture (Armour et al., 2015; 
Rasmussen, Keatley, & Joscelyne, 2014). Ultimately, the field’s understanding of PTSD 
has evolved, culminating in a shift away from a strict classification as an Anxiety 
Disorder into a new, separate diagnostic category in the fifth edition of the DSM (DSM-
5; Friedman, 2013). 
Clinical Outcomes 
 
In the face of significant advances in the field’s understanding of PTSD, current 
conceptualizations of PTSD etiology, course, and appropriate treatments are hotly 
debated (Ehlers et al., 2010; Wampold et al., 2010). Despite the longstanding history of 
the field of psychology acknowledging the deleterious impacts of trauma on 
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psychological well-being (van der Kolk, 2000), many researchers have noted a lack of 
outcome data from PTSD treatment programs across trauma-affected populations 
(McGuigan, 2013; Najavits & Hien, 2013; Steenkamp & Litz, 2013; Cloitre, 2015).  
A lack of clinical outcome data is concerning for multiple reasons. First, the 
prevalence rates of PTSD across the world are higher than previously anticipated. The 
National Comorbidity Survey Replication (NCS-R; Kessler et al., 2005) is a nationally 
representative, face-to-face, epidemiological, diagnostic survey of English-speaking 
United States residents. Using the World Mental Health (WMH) survey initiative version 
of the World Health Organization (WHO) Composite International Diagnostic Interview 
(CIDI; Kessler & Üstün, 2004), interviewers from the University of Michigan found the 
prevalence of PTSD to be approximately 3.6% in men and 9.7% in women (Kessler et al., 
2005). Given the current prolonged state of warfare engagement, incidence rates of PTSD 
are expected to increase among members of the United States military in the coming 
years (Bardhoshi et al., 2016). In conflict zones, this rate increases dramatically, as can 
be seen in the epidemiological, diagnostic study conducted by De Jong, Komproe, 
Spinazzola, van der Kolk, and Van Ommeren (2005) with participants from Ethiopia (n = 
1,200), Algeria (n = 652), and Gaza (n = 585). In these regions, scores on the Structured 
Interview for Disorder of Extreme Stress indicated that 37% of Algerian participants, 
18% of Gazan participants, and 16% of Ethiopian participants would likely meet criteria 
for a diagnosis of PTSD. These numbers indicate large numbers of people across the 
world are in need of effective treatment, especially given the low rate of naturalistic 
PTSD remission and the large cost burden of chronic PTSD to both the individual and 
society (Galatzer-Levy et al., 2013; Zatzick et al., 1997).  
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The second reason a lack of outcome data for PTSD treatment programs is 
concerning are the well-documented consequences of failing to inform clinical practice 
with clinical data (Spinazzola, Blaustein, & van der Kolk, 2005). Without consistently 
gathered patient outcome data, the quality, consistency, and accountability of care 
environments cannot be reliably determined (Brown, Burlingame, Lambert, Jones, & 
Vaccaro, 2001). There is also evidence that without measuring clinical effectiveness, 
therapist skill can deteriorate, which results in poor delivery of service and, potentially, 
the inability to demonstrate value to customers (e.g., taxpayers and patients; Fortney et 
al., 2017). Conversely, the benefit of conducting comprehensive outcome research and 
using that research to inform practice is clear (Prescott, Maeschalck, & Miller, 2017). 
Measurement-based care (MBC) can help providers identify high-risk patients, foster 
coordination between care team members, and improve the therapeutic relationship 
(Fortney et al., 2017). Most importantly, the collection of appropriate outcome data can 
be used to inform treatment results in both symptom reduction (Prescott, Maeschalck, & 
Miller, 2017) and improve quality of life (Scott & Lewis, 2015). 
Processes of Well-being Over Time 
 
 While it is essential that PTSD research continue to assess both symptom 
reduction and quality of life, an important area of emerging research concerns the impact 
of change in core processes of well-being on PTSD outcomes. It is not enough to 
understand whether PTSD treatment impacts both symptom severity and quality of life; 
research also needs to explore how change in processes of well-being over the course of 
treatment impact relevant outcomes (Hofmann & Barlow, 2014). Identifying which 
processes to examine requires a thorough conceptualization of well-being broadly and an 
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explication regarding how these processes function to promote or restrict the cultivation 
of well-being in people with PTSD. A full discussion of relevant literature is included in 
the next chapter, though it is clear that more work needs to be done before any firm 
conclusions can be reached confidently.  
In the absence of definitive research, several findings have emerged that suggest 
processes of well-being that appear to be prime candidates for further exploration. These 
processes include psychological flexibility, emotion regulation, present-moment 
awareness, self-compassion, and interpersonal vulnerability and connection (Boyd, 
Lanius, McKinnon, 2018; Gu et al., 2015; Hoffart, Øktedalen, & Langkaas, 2015). The 
evidence in support of present-moment awareness (e.g., Boyd et al., 2018) and emotion 
regulation (Barlow, 2014) as core processes of well-being in PTSD is established and 
strong. There is also evidence that exposure-based treatments are especially effective at 
addressing emotion regulation and present-moment awareness, as the movement towards 
willingly tolerating distressing emotions in the moment builds up emotion regulation 
skills behaviorally and neurobiologically (Frank et al., 2014; Gratz & Tull, 2010; Yehuda 
et al., 2015). 
The importance of psychological flexibility, self-compassion, and vulnerability 
and connection in interpersonal relationships on PTSD outcomes is less clear. 
Evolutionary psychologists have hypothesized that compassion towards others, 
compassion towards self, and receiving compassion from others (Gilbert, 2010) are core 
components of multi-level evolutionary selection that allows human beings to 
successfully function in groups (Hayes, 2019). From this perspective, creating a context 
in which interpersonal connection can occur is likely to facilitate the cultivation of well-
6
being. This view has been supported by findings that people with PTSD have experienced 
improvements in quality of life following an explicit focus on positive interpersonal 
interactions (e.g., Markowitz et al., 2015). Importantly, there is also evidence that for 
positive interpersonal interactions to occur, a willingness to engage in interpersonal 
interactions characterized by vulnerability must be present (Jordan, 1990; Kohlenberg et 
al., 2015; Reis & Shaver, 1988). Within this evidence is a pattern that suggests courage to 
engage in interpersonal relationships might be a key process of well-being, an approach 
which is integrated in evidence-based treatment (e.g., addressing intimacy and trust in 
Cognitive Processing Therapy [CPT]), yet not fully explored in the current PTSD 
literature (Cloitre, 2015).  
This focus on interpersonal connection and interpersonal courage has often been 
neglected in traditional treatment models for PTSD, as the need to reduce core PTSD 
symptoms (e.g., avoidance, hyperarousal) has taken precedence (Cloitre, Miranda, 
Stovall-McClough, & Han, 2005). Indeed, this symptom reduction approach targets 
essential components of the PTSD experience, and contemporary evidence-based 
approaches (e.g., Prolonged Exposure for PTSD, CPT) have considerable evidence 
supporting their ability to reduce PTSD symptomatology (Barlow, 2014; Cusack et al., 
2016). However, these evidence-based approaches focus on restructuring dysfunctional 
beliefs about self, others, and the world, whereas altering relationships between fear-
triggering stimuli and associated networks via habituation have struggled to consistently 
provide positive results with respect to quality of life for people with PTSD who endorse 
high levels of shame and difficulties connecting with others (Au et al., 2017; Cloitre, 
2015; Green et al., 2017). 
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The experience of shame inherently limits the ability of the individual to connect 
with others, as it is based in strongly held belief that one’s identity is flawed, wrong, or 
broken (Lee, Scragg, & Turner, 2001). One of the most promising interventions for 
targeting shame in PTSD is the cultivation of self-compassion. The definition of self-
compassion most commonly seen in the literature originated from Neff (2003). In this 
definition, self-compassion comprises three components: (1) self-kindness vs. self-
criticism, (2) common humanity vs. isolation, and (3) mindfulness vs. overidentification. 
According to Neff and Dahm (2016), “In order to give oneself compassion, one must be 
able to turn toward, acknowledge, and accept that one is suffering” (p. 2). In some ways, 
this definition of self-compassion provides an alternative definition for shame, and 
validity comparison of self-compassion scales have demonstrated the link between the 
“negative” aspects of self-compassion (e.g., self-criticism) and shame (Kelly, Carter, & 
Borairi, 2014).  
Evidence in support of interventions designed to increase self-compassion and 
decrease shame is moderate in strength, yet growing (Neff & Dahm, 2016). These 
approaches fill an important gap in the literature; shame has been effectively targeted 
cognitively and behaviorally in empirically-supported treatments such as CPT with 
relatively consistent levels of success (Schoenleber & Gratz, 2018), though the reduction 
of reported levels of shame is not necessarily equivalent to active engagement in 
connection with self and others. Additionally, there is some evidence to suggest that 
change in these processes may be best explained by change in psychological flexibility 
(e.g., Levin, Hildebrandt, Lillis, & Hayes, 2012; Meyer et al., 2018; Seligowski, Miron, 
& Orcutt, 2015).  
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Given the previous discussion, clarifying the relationships between psychological 
flexibility, self-compassion, and interpersonal courage in people with PTSD is an 
important empirical and clinical goal. As has been noted by Cloitre (2015), these 
variables should not only be assessed by their relationship to PTSD symptom severity. 
Quality of life (Steenkamp & Litz, 2013) is an important clinical target, as is trauma-
related shame (Neff & Dahm, 2016) due to evidence that suggests high levels of shame 
are often a barrier to successful PTSD treatment (Kelly et al., 2014). Finally, recent 
evidence suggests that evidence-based treatments for PTSD can benefit from including 
core values (e.g., connection with others, fulfilling family relationships) as a motivational 
and behavioral target (Donahue, Huggins, & Marrow, 2017). A focus on these outcome 
variables provides a comprehensive and holistic list of clinical targets that can be 
explored in treatment-seeking populations. 
The Present Study 
 
The present study attempted to explore how self-compassion, psychological 
flexibility, and interpersonal courage functioned as predictors of PTSD symptom 
severity, quality of life, trauma-related shame, and valued living using clinical outcomes 
data obtained from participants who completed treatment at a Prolonged Exposure-based 
partial hospitalization program for PTSD. Using latent growth curve analyses (Little, 
2013; Grimm, Ram, & Estabrook, 2016), this study examined if within-person rates of 
change in self-compassion, psychological flexibility, and interpersonal courage predicted 
the within-person rates of change in PTSD symptom severity, quality of life, trauma-
related shame, and valued living. To complete this task, we tested the null hypothesis that 
there was no difference between the slopes of the rates of change for each predictor 
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variable (Grimm, Ram, & Estabrook, 2016). We also assessed the ability of baseline 
scores for predictor variables to predict scores on our outcome variables at discharge. 
Additionally, reliable change estimates were calculated for the variables under study. 
Type of trauma (impersonal vs. interpersonal) was explored as a covariate. Finally, we 
completed an intent-to-treat analysis to compare (via demographic characteristics and 
scores on the study measures) participants who completed at least two timepoints with 
participants who dropped out of treatment before the second timepoint. A full literature 
review focused on the relationships between predictor and outcome variables is included 
in Chapter 2, though studies that have explored these relationships were cited for each 
hypothesis. 
PTSD Rate of Change Hypotheses (H1) 
We hypothesized that the within-person rate of change (increase) in self-
compassion would predict the within-person rate of change (decrease) in PTSD symptom 
severity (Au et al., 2017; H1a). We hypothesized that the within-person rate of change 
(decrease) in psychological inflexibility would predict within-person rate of change 
(decrease) in PTSD symptom severity (Meyer et al., 2018; H1b). We hypothesized that 
within-person rate of change (increase) in interpersonal courage would predict within-
person rate of change (decrease) in PTSD symptom severity (Jordan, 1990; H1c).  
Quality of Life Rate of Change Hypotheses (H2) 
We hypothesized that the within-person rate of change (increase) in self-
compassion would predict the within-person rate of change (increase) in quality of life 
(Neff & Dahm, 2016; H2a). We hypothesized that the within-person rate of change 
(decrease) in psychological inflexibility would predict within-person rate of change 
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(increase) in quality of life (Levin et al., 2012; H2b). We hypothesized that within-person 
rate of change (increase) in interpersonal courage would predict within-person rate of 
change (increase) in quality of life (Jordan, 1990; H2c). 
Trauma-related Shame Rate of Change Hypotheses (H3) 
We hypothesized that the within-person rate of change (increase) in self-
compassion would predict the within-person rate of change (decrease) in trauma-related 
shame (Au et al., 2017; H3a). We hypothesized that the within-person rate of change 
(decrease) in psychological inflexibility would predict within-person rate of change 
(decrease) in trauma-related shame (Levin et al., 2012; H3b). We hypothesized that 
within-person rate of change (increase) in interpersonal courage would predict within-
person rate of change (decrease) in trauma-related shame (Kelly, Carter, & Borairi, 2014; 
H3c). 
Valued Living Rate of Change Hypotheses (H4) 
We hypothesized that the within-person rate of change (increase) in self-
compassion would predict the within-person rate of change (increase) in valued living 
(Meyer et al., 2018; H4a). We hypothesized that the within-person rate of change 
(decrease) in psychological inflexibility would predict within-person rate of change 
(increase) in valued living (Gloster et al., 2011; H4b). We hypothesized that within-
person rate of change (increase) in interpersonal courage would predict within-person 





Treatment Completion Hypotheses (H5)  
We hypothesized that treatment completion rates would not vary based on 
admission symptom measure scores or demographic variables including race, gender, 
marital status, or education level. 
Interpersonal Trauma Hypotheses (H6)  
We hypothesized that people who experienced interpersonal trauma would 
experience smaller effect size change in PTSD symptom severity than people who did not 
experience interpersonal trauma (e.g., motor vehicle accident, natural disaster, industrial 
accident; Cloitre, 2015; H6a). We hypothesized that people who experienced 
interpersonal trauma would experience smaller effect size change in trauma-related 
shame than people who did not experience interpersonal trauma (Cloitre, 2015; H6b).We 
hypothesized that people who experienced interpersonal trauma would experience 
smaller effect size change in quality of life than people who did not experience 
interpersonal trauma (Cloitre, 2015; H6c). We hypothesized that people who have 
experienced interpersonal trauma would experience smaller effect size change in valued 
living than people who did not experience interpersonal trauma (Levin et al., 2012; H6d). 
Discharge Scores Hypotheses (H7) 
We hypothesized that admission psychological inflexibility scores would be the 
only significant predictor of discharge PTSD symptom severity (Meyer et al., 2018; 
H7a). We hypothesized that admission psychological inflexibility scores would be the 
only significant predictor of discharge quality of life scores (Shenk et al., 2014; H7b). We 
hypothesized that admission self-compassion scores would be the only significant 
predictor of discharge trauma-related shame scores (Au et al., 2017; H7c). We 
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hypothesized that admission psychological inflexibility scores would be the only 
























PTSD Etiological Considerations 
PTSD is one of the few disorders in which an etiological agent can be identified 
(Cloitre, 2015). This is represented in criterion “A” for in the DSM-5 diagnostic criteria: 
“exposure to actual or threatened death, serious injury, or sexual violence…” (American 
Psychiatric Association, 2013, p. 271). The ways in which one can be exposed to actual 
or threatened death, serious injury, or sexual violence have expanded with each iteration 
of the DSM (Cusack et al., 2016), and now include directly experiencing the traumatic 
event, witnessing the traumatic event in person, hearing about a violent or accidental 
traumatic event occurring to close family member or friend, or experiencing repeated 
exposure to details concerning a traumatic event (American Psychiatric Association, 
2013). 
 The presence of an identifiable etiological basis for PTSD allows for targeted 
treatments (e.g., processing the specific way in which someone encountered the traumatic 
event), yet, as can be seen in the wide variety of ways in which someone can encounter a 
traumatic event, the symptom presentation of PTSD is complex and difficult to predict 
(Cloitre, 2015). How to deal with this complexity has been and continues to be a point of 
contention in the PTSD literature (Ehring et al., 2014). One proposed differentiating line 
can be found in the complex PTSD (cPTSD) literature, which has attempted to create a 
new diagnostic category (cPTSD) that expands beyond classic PTSD symptoms and 
includes “additional symptoms including disturbances of affect, self, and interpersonal 
relationships” (De Jongh et al., 2016, p. 361). Importantly, one of the core assumptions of 
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the cPTSD diagnostic category is that specific traumatic stressors (prolonged traumatic 
exposure in the case of cPTSD) result in different causal impacts (Resick et al., 2012).  
This belief, though common, has not held up under scrutiny, but only in terms of 
creating a new diagnostic category (De Jongh et al., 2016). Impacts beyond disorder-
specific symptoms have been shown to be different according to the type of traumatic 
exposure. One such example is that survivors of sexual assault experience a slower return 
to baseline functioning following a sexual assault than disaster survivors, single-incident 
physical injury victims, and first responders (Steenkamp et al., 2012). However, the 
identified symptom presentation across a range of traumatic exposures consistently fall 
within the umbrella of the PTSD diagnostic criteria (Cloitre, 2015). A review of the 
cPTSD literature completed by Resick et al. (2012) concluded that, while there is not 
currently enough research to warrant the creation of a new diagnostic category for 
cPTSD, the heterogeneity of symptoms of functional impacts within the disorder suggests 
the need for better assessment and study of the impact of experiencing different types of 
trauma.  
In terms of PTSD outcomes assessment, one of the messages emphasized in 
Resick et al.’s (2012) and later De Jongh et al.’s (2016) reviews of the cPTSD literatures 
is that new developments in etiological understanding of PTSD, especially in 
differentiating different courses based on predisposing factors or type of trauma 
encounter, must be taken into account when assessing PTSD outcomes. Failure to 
contextualize PTSD outcomes through the person’s trauma history and demographic 
characteristics ignores a large and growing literature base that shows the dynamic nature 
of trauma impact across the lifespan (Resick et al., 2012).  
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This etiological discussion, while not the focus of this paper, is important to place 
several assessment trends into context. Currently, the heterogeneous nature of PTSD 
presentation and course can be overwhelming in terms of treatment and outcome 
assessment (Cloitre et al., 2005) and many studies have failed to provide basic 
methodological information (trauma exposure history, demographics, study exclusion 
criteria) that could be useful in helping to understand the course of PTSD across a variety 
of treatment modalities and pre-trauma factors (Spinazzola, Blaustein, & van der Kolk, 
2005). While an in-depth discussion of the etiology of PTSD is beyond the scope of this 
paper, reviewing the evidence behind the etiological ambiguity of the disorder clarifies 
the criticisms of reporting methodological information in the PTSD treatment outcomes 
literature. 
Models of PTSD Development 
 In addition to a brief overview of the literature on PTSD etiological 
considerations, it is important to review the major theoretical models from which 
empirically supported PTSD treatments are derived. In this section, conditioning models, 
cognitive models, and emotional processing models will be reviewed with respect to the 
development and maintenance of PTSD. 
Conditioning Model  
The conditioning model is one of the first models of PTSD development and 
maintenance and is a strictly behavioral theory based on the Mowrer’s (1960) two-factor 
theory in which an aversive stimulus (i.e. a traumatic event) is classically conditioned to 
be associated with environmental stimuli, which are then avoided (Pomerantz, 2017). The 
temporary reduction in anxiety via the avoidance of trauma-related stimuli then 
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reinforces avoidance, which maintains the fear of trauma-related stimuli (Green et al., 
2017). Higher-order conditioning and stimulus generalization then form new trauma-
related associations that branch off the original conditioned reactions. The literature 
suggests the conditioning model accurately portrays the maintenance of avoidance in 
anxiety, though its applicability for PTSD is questionable (Barlow, 2014; Green et al., 
2017). Specifically, it is not able to account for many of the cognitive or emotional 
elements of PTSD, including dissociation, flashbacks, and negative alterations in 
cognitions and mood (Green et al., 2017; De Jongh et al., 2016). 
Emotional Processing Model  
Following in the footsteps of the conditioning model, the emotional processing 
model (Foa & Kozak, 1991) asserts that PTSD develops when fear networks, which are 
adaptive in many instances (e.g. avoiding dangerous stimuli), are generalized to non-
threatening stimuli and become maladaptive (Green et al., 2017). Maladaptive fear 
structures can include physiological reactivity (e.g., racing heart), behavioral responses 
(e.g., exaggerated startle response), reexperiencing (e.g., flashbacks to the traumatic 
event), and negative appraisals of self, others, and the world (Ehring et al., 2014; Green et 
al., 2017). In the emotional processing model of PTSD, attentional bias towards negative 
appraisals of neutral stimuli lead to the reinforcement of anxiety and avoidance, which is 
a core mechanism of PTSD development and maintenance (Barlow, 2014). Treatment 
then requires modification of both dysfunctional schematic beliefs about the world and 
maladaptive fear networks (Foa et al., 2008). These fear networks are modified through 
integrating new, safe learning that is incompatible with the preexisting maladaptive 
associations, which is one of the core components of PE for PTSD (Barlow, 2014), the 
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evidence for which will be discussed in a later section. While this model represented a 
more sophisticated view of PTSD symptom development and maintenance, it did not 
adequately address flashbacks, dissociation, or nightmares (Green et al., 2017) and as 
such, another PTSD model was developed. 
Cognitive Model 
To address the limitations of the conditioning model and the emotional processing 
model, Ehlers and Clark (2000) suggested a model of PTSD based on the individual 
cognitively appraising a potentially traumatic event as a serious, continued threat. In the 
cognitive model, this sense of threat evolves based on negative appraisals related to the 
traumatic event (e.g. negative views of self, others, and the world) and inability to 
integrate trauma-related memories into autobiographical memory (Ehlers & Clark, 2000). 
Trauma-related memories are fragmented, and thus are difficult to recall in some contexts 
but are easily triggered when faced with trauma-related stimuli (i.e. intrusive thoughts, 
nightmares, and flashbacks; Green et al., 2017). This theory is widely influential in the 
literature and has a great deal of evidence to support its validity, especially with respect 
to the development and maintenance of trauma-related cognitions and memories (Green 
et al., 2017; Ehlers et al., 2010). At this point in time, the cognitive model of PTSD is 
incorporated into most effective models of PTSD treatment, most notably CPT (Green et 
al., 2017; Powers et al., 2010).  
Common Features and Shortcomings 
Together, all three models allow for an increasingly complete understanding of 
PTSD, and in many respects, are compatible and complementary (Green et al., 2017; 
Karlin et al., 2010). However, one of the main elements that each theory fails to fully 
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address, despite the findings from the PTSD etiology literature, is how to account for 
different levels of vulnerability to PTSD across individuals (Green et al., 2017). 
Prognostic Indicators and Risk Factors Assessment 
As can be seen from this discussion, to place treatment outcome results in a 
proper context, it is important to assess identified risk factors for PTSD development and 
ongoing symptom severity. One important gray area to note in the literature is the 
discussion surrounding the impact of traumatic exposure versus other risk factors. It 
should be noted that it is widely accepted that certain factors increase the likelihood that 
someone will develop PTSD. For example, there is a direct, dose-response relationship 
between an individual’s perceived severity and duration/prolongation of a traumatic 
exposure and the risk for PTSD development (Sareen, 2014). It is unclear if this is the 
causal mechanism behind the higher incidence of PTSD development in people with a 
history of childhood sexual abuse (CSA). Regardless, experiencing CSA is one of the top 
prognostic indicators of developing PTSD later in life (De Jongh et al., 2016).  
Peri-traumatic Risk Factors  
Generally, combat exposure, traumatic injury, and rape have been identified as 
types of trauma exposure associated with the highest rates of future PTSD development 
(Briere & Jordan, 2004; Kessler et al., 2017; Sareen, 2014). Additionally, experiencing 
personal versus impersonal trauma is associated with higher risk of PTSD development, 
as is the experience of physical injury during the trauma, particularly a mild traumatic 
brain injury (Briere & Jordan, 2004; Cloitre, 2015; Cusack et al., 2016). During the 
traumatic event, dissociation is associated with increased risk for PTSD development, 
and research into the impact of dissociation on PTSD maintenance is one of the core 
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elements of the proposed cPTSD diagnosis that was integrated into the current DSM-5 
diagnostic framework for PTSD (De Jongh et al., 2016).  
Personality Risk Factors 
Research into personality factors that present risk factors for the development of 
PTSD is relatively weak, as the clear majority of people who present with comorbid 
personality disorders and PTSD have experienced significant CSA (Resick et al., 2012). 
As such, with respect to CSA, researchers have posited that personality factors are risk 
factors for the development of PTSD (Connor, Davidson, & Lee, 2003) and that they can 
be altered and shaped by the experience of CSA (Resick et al., 2012). For non-CSA 
related trauma exposures, there is some evidence that neuroticism and avoidance coping 
styles are risk factors for PTSD (Sareen, 2014), though this finding has not been widely 
replicated or accepted. 
Genetic and Neurobiological Risk Factors  
Another area that warrants a brief discussion is the impact of genetic and 
neurobiological risk factors on the development of PTSD. While the breadth of this 
discussion is outside of the scope of this literature review, there is considerable research 
being conducted into the neurobiological and genetic risk factors for PTSD. 
Neurobiological abnormalities often found in people with PTSD include excessive 
amygdala activation, impaired hippocampal and prefrontal cortex activity, and 
hypothalamic-pituitary-adrenocortical dysfunction, which has been linked specifically to 
the overgeneralization of threats (Bernardy & Friedman, 2015). Much of this research has 
taken place post hoc to the development of PTSD, though there is some evidence that 
early identification of some of these neurobiological abnormalities and immediate 
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intervention might help reduce the risk for PTSD development (Kelmendi et al., 2016). 
However, this avenue is only available to those with the measurement tools necessary to 
detect neurological anomalies. As this research base continues to grow, understanding 
how to assess outcomes related to neurobiological changes following a traumatic event 
may become increasingly important.  
Epigenetics  
The current limitations of the research base preclude fully integrating a discussion 
of genetic and epigenetic factors into this review, yet it is important to note that the next 
frontier for the understanding of PTSD risk factors may be epigenetics and 
intergenerational trauma (Zannas, Provençal, & Binder, 2015). Epigenetics is particularly 
important because studies investigating genetic predictors of PTSD have not been 
successful (Bernardy & Friedman, 2015; Zannas et al., 2015). Epigenetics is a promising 
avenue of research that has corroborated evidence that CSA and multiple traumatic 
experiences are correlated with PTSD development and HPA-axis dysfunction and have 
extended those findings across multiple generations (Zannas et al., 2015). 
Epigenetic research has shown the multigenerational impacts of trauma on genetic 
expression in an increasingly diverse range of samples (Yehuda et al., 2014), and has 
been posited as a lens though which intergenerational, community trauma can be 
explained and ideally, acted upon (Perroud et al., 2014; Zannas et al., 2015). The 
relevance of this emerging line of research to PTSD outcomes research is the potentially 
crucial collaboration between geneticists and PTSD researchers to obtain consent from 
PTSD patients to give peripheral blood tests in large treatment systems and integrate 
epigenetic data into understandings of desired treatment outcomes, including resilience 
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and reduced autonomic activation (Zannas et al., 2015). This research area is still in early 
stages and is not ready to be integrated into clinical feedback. However, the potential is 
immense, and PTSD outcomes researchers should be aware of this potential when 
considering areas for future work. It should be noted that a hypothesized limitation of this 
approach is a decrease in patient rating of treatment acceptability, as blood-draws 
provoke anxiety and discomfort for many people (Zannas et al., 2015). 
Summary of PTSD Risk Factors Literature 
The first-order risk factor for PTSD (and in severe cases, chronic PTSD) appears 
to be continuous exposure to traumatic events (Kessler et al., 2017; Resick et al., 2012). 
Epigenetic research conceptualizes intergenerational trauma as the impact of profound 
prenatal stress on the development of the HPA-axis, which closely resembles the course 
of early-childhood trauma (Perroud et al., 2014). Conceptually, this still places repeated 
traumatic exposure, pre, post, or peri-natal, as the single greatest risk factor in developing 
PTSD. The literature has not yet differentiated the specific time-points during which risk 
is the greatest, though this area is the subject of proposed future research (Zannas et al., 
2015).  
 For PTSD outcomes research, the literature on the risk factors for PTSD 
emphasizes the need to collect data on early childhood experiences (among other 
variables) for inclusion in analysis. However, an important element that is missing from 
PTSD outcomes research is the inclusion and integration of many of the risk-factors 
discussed above, including past treatment engagement, comorbidity, and trauma exposure 
history (Najavits & Hien, 2013). This trend is partially due to a lack of acknowledgement 
of the complexity and heterogeneity of symptom presentations in PTSD, which led to 
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simplistic study designs that did not measure or account for many of the variables 
discussed above (Cloitre, 2015; Wampold et al., 2010). As such, the research on potential 
risk factors for PTSD and the history of non-inclusion in PTSD outcomes studies is a 
concerning gap in the current literature. 
PTSD Symptom Severity Reduction Rationale 
As has been discussed previously in this paper, a focus on symptom severity 
reduction or elimination is an incomplete outcome focus for a variety of mental health 
conditions (Gilbody et al, 2002). While this is still the case in PTSD (as will be discussed 
in later sections), symptom severity is a core predictor of a multitude of other identified 
outcomes, including occupational functioning (Schnurr & Lunney, 2016) and health-
related quality of life (HRQoL), measures of which assess vitality, pain, general health 
perceptions, emotional, physical, and social role functioning (Pagotto et al., 2015, p. 70). 
The discussion of PTSD symptom reduction is complex, requires a review of identified 
symptom clusters, diagnostic understanding of PTSD, and the ways in which symptoms 
have been effectively targeted in PTSD treatment.  
Measuring PTSD Symptom Severity 
 Before discussing specific symptom severity reduction methods, it is important to 
include a discussion of how those symptoms are typically measured and how best 
practice recommendations suggest they should be measured. To that end, Bardhoshi et al. 
(2016) conducted a comprehensive analysis of the most commonly used diagnostic tools 
for PTSD. In conjunction with findings from Erford et al. (2016), it was found that the 
Clinician-Administered PTSD Scale (CAPS), the Impact of Event Scale–Revised (IES-
R), the Posttraumatic Stress Diagnostic Scale (PDS), the PTSD Checklist (PCL), and the 
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Structured Interview for PTSD (SI-PTSD), and the Mississippi Scale for Combat-Related 
PTSD (M-PTSD) are the most commonly used instruments, with the CAPS used the most 
frequently. Each scale has demonstrated adequate reliability and validity, though the 
CAPS, PDS, and PCL have demonstrated the strongest reliability, validity, specificity, 
and sensitivity evidence (Bardhoshi et al., 2016; Erford et al., 2016; Evans, 2012; Green 
et al., 2017).   
 Additionally, this study assessed effect size comparisons between outcome 
measures. After this analysis, four instruments stood out as having the highest validity, 
reliability, and consistent effect size evidence: the CAPS, the PCL, the SI-PTSD, and the 
M-PTSD. Among these instruments, the CAPS, PCL, and M-PTSD yielded the strongest 
evidence overall, though the use of the M-PTSD is typically only appropriate for veterans 
or people who have experienced combat-related trauma. As such, the PCL and CAPS 
have the greatest utility across populations, which is reflected in the results from meta-
analyses (discussed at length later in this paper) that show that these two instruments 
have strong psychometric properties in civilian, military, and refugee samples (e.g., 
Cusack et al., 2016; Kline et al., 2018). Given the strong suggestion that effective 
outcome research is cost-effective for patients, providers, and the general population 
(Fortney et al., 2017), it is worth noting that these two instruments are naturally 
complementary, free to administer (Bardhoshi et al., 2016), help clinicians track specific 
symptom cluster changes through factor analytic assessment (Armour et al., 2015), and 
allow for diagnostic evaluation and continuous assessment (Barlow, 2014).  
 One major limitation of the PTSD-specific measures literature is that PTSD 
assessments do not focus on quality of life (Cloitre, 2015) and measures that include 
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validity are largely absent. Assessing quality of life and other appropriate measures of 
functionality for PTSD populations will be discussed later in this review, and the 
literature base on this topic has a good deal of depth and breadth. However, measuring 
validity of symptoms in PTSD, especially on a wide scale, is challenging. This is likely 
due to a cost barrier, as clinicians are much more likely to administer free-to-use 
assessments (Bardhoshi et al., 2016). This likely accounts for the widespread use of the 
PCL and the CAPS. Unfortunately, assessments with both validity measures and strong 
psychometric properties (e.g., the Trauma Symptom Inventory [TSI] and the Detailed 
Assessment of Posttraumatic Stress [DAPS]) are not free to use and are thus 
underutilized by clinicians and underrepresented in the research literature (Evans, 2012). 
While it is encouraging that the most widely used assessments for PTSD have strong 
psychometric properties and can be used together to establish convergent validity, 
symptom validity measures, which may include personality tests with validity measures 
(e.g., MMPI-2, PAI) are important to include to adhere to best practices in PTSD 
assessment (Bardhoshi et al., 2016; Cloitre, 2015; Evans, 2012).  
PTSD Symptom Severity Reduction Methods 
The clear majority of the initial literature found for this paper revolved around 
methods of symptom severity reduction in PTSD, specifically the efficacy of different 
treatment modalities. This is not surprising, as controversy and debate surrounding 
appropriate treatments for PTSD has been prevalent since the introduction of the disorder 
into the DSM (Pomerantz, 2017). As was mentioned in the previous section, reducing 
specific PTSD-related symptoms is an important part of PTSD treatment, and as such, it 
is necessary to review the treatment effectiveness literature for PTSD. After reviewing 
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the literature, cognitive processing therapy (CPT; Resick & Schnicke, 1992), eye 
movement desensitization and reprocessing (EMDR; Shapiro, 2001), cognitive therapy 
(CT; Ehlers & Clark, 2000), and prolonged exposure (PE) for PTSD (Foa, Hembree, & 
Rothbaum, 2007) are consistently named as the most efficacious treatments for PTSD, 
which is reflected in the American Psychological Association’s Clinical Practice 
Guideline for the Treatment of PTSD (CPG-PSTD; 2017), the findings from which will 
be discussed in greater detail in an upcoming section.  
Other Common Treatment Approaches  
Before fully reviewing the evidence for the PTSD treatments with the strongest 
support, it is important to note other widely-used treatments that have not demonstrated 
strong effect size reductions in symptom severity or other outcome measures. Generally, 
pharmacological treatments alone have failed to demonstrate even medium effect sizes 
(Green et al., 2017), as have non-trauma-focused CBT methods, coping skills training, 
and brief eclectic therapy (Barlow, 2014; Cusack et al., 2016; Kline et al., 2018). One 
controversial approach is stress inoculation training (SIT), which has demonstrated mixed 
efficacy results due to methodological research issues (Green et al., 2017). SIT has, in the 
past, been an EST for PTSD (Barlow, 2014), though multiple meta-analyses conducted in 
the past ten years have not included it in effect size analysis because the strength of the 
evidence is too weak (e.g., Cusack et al., 2016; Ehring et al., 2014; Powers et al., 2010). 
Another modified protocol with a growing body of evidence is skills training in affective 
and interpersonal regulation (STAIR), which was developed for comorbid PTSD and 
substance use (Cloitre et al., 2005; Green et al., 2017). However, the core mechanism of 
change in STAIR appears to exposure-based (Barlow, 2014), and it is unclear if the added 
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components of affective and interpersonal regulation are necessary for symptom 
reduction. Currently, the evidence is not sufficient to discuss STAIR as stand-alone 
empirically supported treatment for PTSD, though the exposure component is highly 
evidence-based (APA, 2017).  
PE for PTSD 
PE for PTSD has one of, if not the strongest evidence bases in support of its use in 
the treatment of PTSD (Barlow, 2014; Karlin et al., 2010). PE is based on the emotional 
processing theory of PTSD development and maintenance and involves engagement in 
both in-vivo and imaginary exposure. In-vivo exposure refers to encountering traumatic 
reminders in a safe, therapeutic context, while imaginal exposure refers to processing 
traumatic memories through reading, listening to, or reciting a traumatic memory 
narrative (Foa et al., 2007). PE for PTSD is typically conducted in an outpatient setting, 
but recent evidence has demonstrated medium to large effect sizes in community clinics 
(Wade, Lau, & Nixon, 2018), psychiatric hospital settings (Cusack et al., 2016), and in 
primary care (Cigrang et al., 2017; Pomerantz, 2017).  
Additionally, according to an RCT from Rothbaum et al. (2012), when PE for 
PTSD and a comparison group of breathing and relaxation training were delivered to 
emergency room survivors within half a day of experiencing a single-event trauma, only 
PE for PTSD appears to function as a protective factor against the future development of 
PTSD. PE for PTSD reports dropout rates (20-21%) similar to the rates of other trauma 
therapies and much lower than rates found in pharmacological interventions (Olatunji, 
Deacon, & Abramowitz, 2009). It should be noted that some have suggested that this 
number is grossly deflated due to the reliance on RCT design for meta-analysis of 
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dropout rates (Najavits, 2015), though the strength of this evidence is not strong enough 
to assert that dropout rates for PE for PTSD are substantially higher in community 
settings than in RCTs (e.g., Wade et al., 2018). 
While the strength of the evidence in favor of patient preference for PE for PTSD 
was not strong enough for inclusion in the 2018 CPG-PTSD, there is evidence that 
patients find PE tolerable and are not caused harm by engaging in the treatment (Farrell, 
Deacon, Dixon, & Lickel, 2013), despite many the prevailing belief among many 
clinicians that PE for PTSD is intolerable to many patients (Hipol & Deacon, 2013; 
Olatunji et al., 2009). PE is best delivered in individual therapy, as meta-analyses of PE 
for PTSD in group therapy have shown discouraging results (Haagen, Smid, Knipscheer, 
& Kleber, 2015; Murphy & Busuttil, 2015). 
Finally, PE has a strong evidence for treating PTSD with complex (Karlin et al., 
2010) and comorbid presentations. In a pilot RCT measuring the effectiveness of 
combining PE for PTSD and Dialectical Behavioral Therapy (DBT) for women with 
comorbid borderline personality disorder, PTSD, and self-injury, moderate to large effect 
sizes were found for the combined treatment with respect to global functioning, 
depression, anxiety, shame, posttraumatic cognitions, and shame (Harned, Korslund, & 
Linehan, 2014). These findings have not been replicated extensively (Green et al., 2017), 
though they are encouraging given that approximately 25%-60% of patients with 
borderline personality disorder have comorbid PTSD (Pagotto et al., 2015). Moderate to 
large effect sizes have been demonstrated when using PE to treat PTSD and comorbid 
psychosis, major depression, and substance use (McGuigan, 2013), although many RCTs 
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reviewed in meta-analyses exclude patients with comorbid substance use or suicidality 
(Cusack et al., 2016).  
CPT  
Based on Ehlers and Clark’s (2000) cognitive model, CPT targets cognitive 
appraisals of the traumatic event, specifically maladaptive beliefs about self, others, and 
the world (Green et al., 2017). Skills such as thought evaluation and thought challenging 
are taught through the use of Socratic questioning in session, which is then continued by 
the client outside of session (Resick et al., 2012). During treatment, the client writes an 
impact statement that summarizes the ways in which the trauma has affected functional 
areas of life, which are then targeted for intervention (Resick et al., 2012). While the 
original form of CPT included writing an account of the trauma and processing it with the 
therapist and outside of session as needed, the treatment is often delivered without this 
component (Resick et al., 2008). Interestingly, while component analyses of cognitive 
behavioral therapy have failed to demonstrate the efficacy of thought challenging and 
modification (Longmore & Worrell, 2007; Green et al., 2017), components analyses of 
CPT have demonstrated that the modification of trauma related thoughts is both 
necessary and sufficient for change in PTSD (Ehlers et al., 2010). These components 
analysis findings have not been replicated adequately, though the average effect size 
evidence for CPT is medium to large (Ehring et al., 2014; Powers et al., 2010). Like PE 
for PTSD, CPT has been shown to be more efficacious when delivered in an individual, 
rather than group format (Resick et al., 2017). The effect-size evidence for CPT and 
comorbid conditions is mixed, and the evidence base lacks enough depth and breadth to 
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make broad-base conclusions, though results appear to be mostly positive (Ehring et al., 
2014). 
In some guides to effective PTSD treatments (e.g., APA, 2018), cognitive therapy 
without specific PTSD focus has been determined to be an empirically validated 
approach to reducing PTSD symptoms, especially posttraumatic cognitions (Barlow, 
2014, Green et al., 2017). However, the PTSD-tailored form of cognitive therapy found 
in CPT is thought to be a more efficacious method, though a component analysis focused 
on examining these two related approaches has not yet been conducted. Information on 
whether or not each study reviewed contained a writing component was not provided, so 
it is unclear whether meta-analytic results support Ehlers et al.’s (2010) component 
analysis findings. It should be noted that the core mechanism of change in CPT has been 
purported to be exposure, as processing cognitions related to the traumatic event can be 
viewed as a form of exposure to that traumatic event, especially given the complex 
connectivity of trauma-related memories to the event itself (Green et al., 2017). 
Nevertheless, the strength of the evidence for CPT is strong, overall.  
EMDR  
EMDR (Shapiro, 2001) is widely-used treatment for PTSD that was developed 
after Shapiro discovered that lateral eye movements were able to help facilitate the 
processing of her own difficult thoughts. She then extrapolated this personal discovery to 
other forms of difficult thoughts, specifically posttraumatic cognitions in PTSD (Green et 
al., 2017). EMDR typically consists of eight phases of treatment that consists of, “history 
taking, client preparation, target assessment, desensitization, installation, body scan, 
closure, and reevaluation of treatment effects” (Barlow, 2014, p. 76). The model of 
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EMDR treatment is based on a modified Cognitive Processing model that links past 
cognitive appraisals of traumatic events, current avoidance of traumatic triggers, and the 
presence of maladaptive neural networks to the development and maintenance of PTSD 
(Shapiro, 2001). In EMDR, the goal of treatment is to reframe negative cognitions 
surrounding the trauma, decrease avoidance of trauma-related triggers, develop adaptive 
responses in response to trauma-related triggers, and, most importantly, allow for the 
reintegration of newly learned responses into adaptive neural networks via rapid eye-
movement (Shapiro, 2001).   
EMDR is controversial in that evidence is conflictual at best concerning the 
mechanism of change, with some researchers suggesting that rapid, lateral eye-movement 
is a key component of the treatment (e.g., Pitman et al., 1996; Shapiro, 2001), and others 
noting the similarity of the treatment to exposure and the lack of component analysis 
evidence to suggest rapid eye movement is necessary (Barlow, 2014; Green et al., 2017). 
While there are some studies that have suggested a neurobiological mechanism linking 
rapid eye movement in EMDR to REM sleep cycles and the co-occurring priming of the 
hippocampus to integrate traumatic memories into larger, less activating semantic 
networks (e.g., Stickgold, 2002), there is not enough evidence to definitively state that the 
rapid eye movement component of EMDR is necessary to achieve positive clinical 
outcomes. In terms of overall effectiveness, most meta-analyses yield medium effect 
sizes versus control and little difference between EMDR and active treatments (Ehring et 
al., 2014; Powers et al., 2010). As such, EMDR appears to be an effective treatment for 
PTSD, though slightly less effective than PE for PTSD (Kline et al., 2018) and with little 
31
evidence in support of the necessity of the rapid eye movement component of the 
treatment protocol. 
Meta-analytic Discussion Rationale  
Meta-analytic studies provide the most comprehensive review of the comparative 
effectiveness of PTSD treatment approaches (Barlow, 2014). While many meta-analyses 
for PTSD have been conducted (McKay et al., 2017), the following four recent meta-
analyses provide a recent and comprehensive view of PTSD treatment effectiveness in 
both symptom severity and several other notable outcomes. These meta-analyses will be 
discussed in order of publication date, beginning with the least recent study. 
Powers et al., (2010). This meta-analysis was conducted in 2010 and included a 
total of 13 studies and 675 participants. The purpose of the study was to assess the 
strength of the RCT evidence for PE for PTSD. Primary outcome measures were focused 
on PTSD symptom severity and included the CAPS and the PCL, while secondary 
outcome measures included the Beck Depression Inventory II (Beck, Steer, & Brown, 
1996) and the State/Trait Anxiety Inventory (Spielberger, 1972), among other 
instruments with established reliability and validity (Bardhoshi et al., 2016). Hedge’s g 
was utilized due to the small sample size of several of the RCTs reviewed, which is in 
accordance with recommendations from Ferguson (2009). Publication bias was tested 
using the fail-safe N and heterogeneity among studies was accounted for appropriately 
using the Q statistic, which are both methods recommended for use in meta-analysis by 
Schmidt and Hunter (2014). Overall, the methodological and statistical rigor appears to 
be strong. 
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Results demonstrated large effect sizes for PE for PTSD versus control on both 
primary (Hedges's g=1.08, SE=.20, 95% CI[.69, 1.46]) and secondary outcome measures 
(Hedges's g=.77, SE=.12, 95% CI[.53, 1.01]). The effect size of PE for PTSD versus 
waitlist was large (Hedges's g=1.51, SE=.21, 95% CI[1.12, 1.90]). The effect size of PE 
for PTSD versus psychological placebo was medium to large (Hedges's g=.65, SE=.19, 
95% CI[.29, 1.01]). Only 7 of the original 13 studies included follow-up data. At follow-
up (between 1 and 12 months depending on the study), the effect size for PE for PTSD 
versus control was medium to large (Hedges's g=.68, SE=.21, 95% CI[.27, 1.10]). 
Despite the strong evidence found in support of PE for PTSD, comparison analysis for 
six studies including PE, CPT, EMDR, CT, and SIT did not find a difference between PE 
for PTSD and the other active treatments (Hedges's g=-.07, SE=.18, 95% CI[-.42, .28]). 
Given this evidence, the authors concluded that PE for PTSD is an effective treatment, 
though the lack of effect size differentiation between PE and other active treatments is 
puzzling. The authors suggested that a single process, exposure, is common across 
treatments, and might account for the lack of variation in results. 
Ehring et al., (2014). In a later meta-analysis, the necessity of trauma-focused 
treatment for PTSD was examined in adult survivors of childhood sexual abuse. Most 
studies reviewed were RCTs, but controlled research that did not meet RCT criteria was 
also included, in large part due to the limitations of the current research base on this 
population. This meta-analysis is inherently limited by its inclusion criteria (only adult 
survivors of childhood sexual abuse), though it adds to the literature by addressing a 
group that previously had only been systematically examined in the cPTSD research 
(Cloitre, 2015). This meta-analysis also sought to “investigate whether trauma-focused 
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treatments differed from non-trauma-focused interventions regarding the relative 
efficacy” (p. 647). Finally, this meta-analysis compared individual and group treatments 
across multiple treatment modalities. 
Methodologically, this analysis is highly rigorous. As was in the case in the meta-
analysis from Powers et al. (2010), all instruments used (e.g., CAPS, PCL variants) had 
established reliability and validity (Bardhoshi et al., 2016). Additionally, Hedge’s g was 
appropriately utilized due to the inclusion of studies with small sample sizes (Ferguson, 
2009). Publication bias was tested using the funnel plot method and heterogeneity was 
addressed using the Q statistic, which are both methods recommended for use in meta-
analysis by Schmidt and Hunter (2014). A priori planning rigor was strong in this study 
as well, as it also included a pre-established study selection and data analytic plan. 
Sixteen total studies were reviewed. Most studies were manualized and (k = 13) and used 
a structured clinical interview (k = 13). Follow-up data (6-12 months) was better than was 
seen in Powers et al. (2010), though still underwhelming (k = 11). Dropout was also 
assessed. This meta-analysis did not directly compare different types of cognitive-
behavioral treatments designed for PTSD and collapsed PE for PTSD, CPT, and STAIR 
under a cognitive-behavioral intervention for PTSD (CBT-P) umbrella.  
The results from this meta-analysis clarify the benefits of trauma-focused 
treatments for adult survivors of childhood sexual abuse. Between-groups effect sizes at 
post-treatment versus waitlist were larger for CBT-P (Hedges's g=.88, SE=.30, 95% 
CI[.30, 1.47]) than for non-trauma-focused CBT (Hedges's g=.48, SE=.39, 95% CI[-.28, 
1.23]), and EMDR (Hedges's g=.76, SE=.34, 95% CI[.38, 1.71]). Between-groups effect 
sizes at post-treatment versus treatment-as-usual (TAU) / placebo were again larger for 
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CBT-P (Hedges's g=1.72, SE=.58, 95% CI[.58, 2.87]) than for non-specific CBT 
(Hedges's g=-.12, SE=.12, 95% CI[-.37, 0.12]), and EMDR (Hedges's g=.39, SE=.38, 
95% CI[-.36, 1.13]). Effect sizes at follow-up were almost identical, with CBT-P 
outperforming non-trauma-focused interventions. Dropout for all treatments were 
assessed to be approximately 20%, which is consistent with rates seen across the PTSD 
literature (Olatunji et al., 2009). Group treatments (Hedges's g=.73, 95% CI[.60, .86]) 
were found to be less efficacious than individual treatments (Hedges's g=1.18, 95% 
CI[.99, 1.37]). 
Notably, non-specific CBT was not effective in treating PTSD based on the 
confidence interval values. The lack of ability to compare across specific treatment 
modalities within CBT-P is indicative of a dearth of RCTs for this population, though the 
result that trauma-focused interventions are more effective in treating PTSD than non-
trauma-focused interventions is important, especially given the assertion that all PTSD 
treatments are equivalent (e.g., Wampold et al., 2010). Inclusion of outcome measures 
beyond symptom severity was lacking, which is a common shortcoming of RCT designs 
(Gilbody et al., 2002). 
Cusack et al., (2016). While most treatment guidelines for PTSD (e.g., APA, 
2018; Foa, Keane, Friedman, & Cohen, 2008) recommend trauma-focused treatments as 
first-line interventions and require at least one RCT that meets strict methodological 
criteria (missing data analysis, measures of dropout, blinding assessors; c.f. Powers et al., 
2010), there is still a great deal of variance in inclusion criteria and methodological 
approaches across treatment guidelines. Additionally, there is a lack of direct comparison 
of trauma-focused treatments, specifically cognitive therapies and exposure therapies. In 
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response to this gap in the literature, Cusack et al. (2016) conducted the largest meta-
analysis of psychotherapeutic interventions for PTSD to date, reviewing 64 trials 
published between 1980 and 2014. 
Methodological rigor in this study was extremely strong, as it utilized essentially 
the same methods as Ehring et al. (2014) while adding several important modifications. 
First, two reviewers independently reviewed articles for inclusion criteria, and all 
disagreements were arbitrated by a third party experienced with meta-analytic methods. 
Second, “studies were required to assess at least one of the following outcomes: PTSD 
symptoms, remission (no longer having symptoms), loss of PTSD diagnosis, quality of 
life, disability or functional impairment, return to work or active duty, or adverse events” 
(p. 131). Third, bias was assessed more strictly than in previous meta-analyses by 
assessing selection bias, potential confounds, detection bias, and attrition bias (p. 131). 
Sample sizes in this analysis were generally larger due to the inclusion of more recent 
studies, with the largest sample being 563 and the smallest being 10. Most studies 
analyzed psychological treatment alone, and the majority of participants experienced 
severe PTSD (CAPS total score = 60-79).  
The full extent of the findings from the meta-analysis is too great to include in 
this review, though several findings are notable. CPT, cognitive therapy, PE for PTSD, 
and EMDR all demonstrated at least medium effect size symptom reductions, while 
narrative exposure therapy and brief electric psychotherapy showed small effect sizes. 
Because symptom reduction was measured across a variety of sample sizes, standard 
mean difference (SMD), which is equivalent to Cohen’s d (1992) but able to compare 
across different sample sizes, was reported for PTSD symptoms and weighted mean 
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difference (WMD) was reported to represent change from baseline data. The only two 
large effect sizes in this meta-analysis were both found for PE for PTSD. Specifically, PE 
for PTSD showed large effect sizes for PTSD symptom reduction as measured by the 
CAPS (SMD=-1.27, 95% CI[-1.54, -1.00], N = 387) and depression symptoms as 
measured by the BDI (WMD=-8.2, 95% CI[-10.3, -6.1], N = 363).  
Echoing findings from the Ehring et al. (2014) paper, comparison findings were 
largely inconclusive, as the head-to-head evidence was insufficient. The only notable 
finding here was that PE for PTSD is moderately favored over relaxation training. These 
comparison findings are interesting, as relaxation training is included in the PE for PTSD 
protocol (Foa et al., 2007). Although the strength of this evidence is not strong enough to 
assert any definitive conclusions, it is worth exploring in future dismantling research. 
Although adverse effects of treatment engagement (e.g., suicidality, dropout, self-harm) 
were assessed, evidence was not sufficient to draw any strong conclusions. As was the 
case in the Powers et al. (2010) meta-analysis, the exclusion of comorbid suicidality and 
substance use confounded analysis to a certain extent, although more studies were 
assessed that included that information than in previous meta-analyses. Comorbid 
substance use and PTSD is an area of expanding research that still needs to grow before 
analyses of this magnitude can be undertaken. Evidence was insufficient to draw strong 
conclusions about long-term efficacy of any treatments. As has been noted in previous 
discussions of CPT and cognitive therapy, the distinction between the two approaches 
appears to be largely arbitrary, and little evidence suggests that they differ. It should be 
noted that the majority of results were drawn from outpatient settings, and there is a need 
for additional research across various settings (Cloitre, 2015). Most of the studies 
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reviewed assessed PTSD and/or depression symptoms, and other outcomes were not 
utilized enough to include in analysis. Ultimately, this meta-analysis presents the 
strongest evidence in support of PE for PTSD over other treatments in terms of PTSD 
and depression symptom reduction, though the lack of head-to-head trials limits the 
ability to make comparative conclusions. 
Kline et al., (2018). The most recent meta-analysis reviewed attempted to expand 
beyond the limited timeframes often seen in RCTs and assess the long-term efficacy and 
follow-up evidence for psychological treatments for PTSD. This meta-analysis built upon 
and cited the previous meta-analyses discussed in this paper and was most 
methodologically similar to Cusack et al. (2016). Specifically, the approach to inclusion 
criteria, study bias, and multiple rater methodology was adopted from Cusack et al. 
(2016). Additionally, to account for the specific focus on long-term follow-up data, 
Cohen’s d was modified to include the pretreatment standard deviation, which is an 
appropriate statistical modification (Schmidt & Hunter, 2014). As such, methodological 
rigor was high. Additionally, this study included information concerning population (e.g., 
civilian, military, refugee), type of trauma, and primary outcome measures, which 
allowed for increased specificity in analysis.  
In total, the 32 studies reviewed comprised 3399 patients with sample sizes 
ranging from 30 to 284 (median = 92, SD = 57). Seventy-two conditions met full 
inclusion criteria, and the mean effect size across conditions was large (Cohen’s d = 1.88, 
95% CI[1.68, 2.08]) for pretreatment to follow-up and small (Cohen’s d = .17, 95% 
CI[.10, .23]) for posttreatment to follow-up. All follow-up data was collected at least six 
months post-treatment, which is long enough to reliably determine lasting treatment 
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effects (Trauer, 2010). Most conditions obtained follow-up data at six months (k = 48, 
67%) and one year (k = 19, 26%), with several studies obtaining follow-up data at nine (k 
= 3, 4%) and 20 months (k = 2, 2,8%). Dropout rates in the studies reviewed were 22%, 
which is consistent with findings from previous meta-analyses (e.g., Ehring et al., 2014; 
Cusack et al., 2016; Powers et al., 2010). In terms of population studied, this analysis 
reviewed 23 civilian studies (9 female-specific), 7 military studies, 1 study focused on 
Cambodian refugees, and 1 study focused on Sudanese refugees. Most studies assessed 
mixed trauma, which was not further defined, and utilized the CAPS as the primary 
outcome measure.  
As has been shown in previous meta-analyses (e.g., Cusack et al., 2016; Ehring et 
al., 2014), active treatments (Cohen’s d = 2.14) performed substantially better than 
control conditions (Cohen’s d = 1.04; p < .01) in the pretreatment to follow-up period. 
However, long-term effects were less encouraging, with no significant differences noted 
between active treatments and control in the posttreatment to follow-up period. The only 
treatments that demonstrated long-term efficacy compared to other conditions were 
exposure-based therapies (largely PE for PTSD; Cohen’s d = .27). Importantly, 
population type, number of sessions, and type of trauma did not predict effect size 
differences for active treatments during the pretreatment to follow-up period. In the 
posttreatment to follow-up period, an index trauma of childhood abuse was related to 
greater gains at follow-up (Cohen’s d = .46) than traumas that occurred in adulthood 
(Cohen’s d = .12) or mixed trauma focus (Cohen’s d = .14). Additionally, there was 
evidence that attrition effects did not impact results if individuals were randomized 
immediately as opposed to only being randomized at follow-up. Finally, effect sizes 
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began to increase with longer follow-up times, suggesting the need to assess beyond 6 
months posttreatment, especially given research that suggests PTSD can lead to long-
term residual symptoms and decreased quality of life (Bryant et al., 2016; Cloitre, 2015). 
The long-term efficacy of PE for PTSD is especially relevant to assess in the light of 
these findings, as there is very little evidence beyond this meta-analysis concerning 
which treatments are effective at maintaining treatment gains long-term.   
PTSD Symptom Severity Reduction Summary 
While multiple treatments appear to be efficacious for PTSD (e.g., CPT and PE 
for PTSD), PE for PTSD has the strongest research base, albeit by a slim margin. 
Specifically, PE for PTSD shows the largest effect size gains of all trauma-focused 
treatments across meta-analyses, has the strongest evidence with respect to comorbid 
conditions, is not significantly different from other active treatments in terms of dropout, 
and is the only active treatment to demonstrate long-term (6 months and beyond) efficacy 
in terms of PTSD symptom severity reduction. There is evidence that PTSD-specific 
cognitive restructuring found in CPT focused on safety, trust, power/control, esteem, and 
intimacy is an effective component to include in trauma treatment, though there is still 
debate as to the underlying mechanism of change with respect to this approach.  
Assessments including measures of validity (e.g., TSI, DAPS, MMPI-2) were 
largely absent from the symptom severity review, which is a major oversight given the 
findings from several studies that have emphasized the evidence that instances of PTSD 
are overreported and occasionally malingered (Evans, 2012). While there is not a 
consensus in the literature about the severity of this problem (e.g., Poyner, 2010), best 
practices of obtaining collateral information such as medical and mental health records 
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and including at least one measure of validity were not followed in the studies reviewed. 
While this does not discount the findings from these meta-analyses, it does require 
additional replication of these findings in conjunction with collateral information and a 
measure of malingering. Evidence suggests the Personality Assessment Inventory (PAI), 
the DAPS, Morel Emotional Numbing Test-Revised (MENT-R; Morel, 1998) and the 
TSI to be particularly effective at detecting PTSD malingering when given in some 
combination (Evans, 2012; Messer & Fremouw, 2007; Wooley & Rogers, 2015). 
Additional findings from this section of the review emphasize the utility of the CAPS as a 
primary symptom outcome measure, especially when measurement only occurs at admit, 
discharge, and follow-up. Symptom specific measures of depression and other comorbid 
disorders specific to populations under study are recommended as well.  
Functional Impacts of PTSD on Quality of Life 
 PTSD has been conceptualized as a whole-life disruption (Levers, 2012), as 
evidence shows experiencing PTSD symptoms is linked to spiritual (Kopacz, Currier, 
Holland, Drescher, & Pidgeon, 2015), family and marital (Eisenman et al., 2008), 
occupational (Schnurr & Lunney, 2016), physical health (Agorastos et al., 2014), and 
interpersonal (Cloitre et al., 2005) impairment. These domains are often assessed together 
under the umbrella term “quality of life.” There is also evidence that even in early-
remitting cases of PTSD (i.e. naturalistic loss of diagnosis within five months), residual 
functional impacts persist (Bryant et al., 2016). As has been discussed throughout this 
review, thorough, individualized assessment is especially important in PTSD given the 
heterogeneity of symptom and functional impairments (Cloitre, 2015). Appropriate 
methods for assessing functional impairment include Melchert’s (2011) biopsychosocial 
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assessment, global functioning measures (Brown et al., 2001), domain-specific self-report 
measures (Fortney et al., 2017), and medical / occupational records to assess concrete 
functional impairments (Thornicroft & Slade, 2014). In the next section, the literature on 
functional impairment and quality of life in PTSD will be reviewed with the intention of 
identifying important areas of outcomes assessment. 
Spiritual Functioning  
Spirituality in PTSD has been proposed as a potentially important protective 
factor, especially for veterans experiencing moral injury (Kopacz et al., 2011) and 
survivors of sexual assault (Resick et al., 2012). However, there is currently a dearth of 
literature on spirituality and PTSD specifically, as it is typically represented as a single 
question in the construct of posttraumatic growth (Frazier, Conlon, & Glaser, 2001) and 
is more loosely connected to moral injury (Kopacz et al., 2011). Additionally, there does 
not appear to be consistent evidence of spiritual change that predicts improved PTSD 
outcomes, which may be due to the heterogeneity of religious beliefs and behaviors held 
across individuals (Chen & Koenig, 2006). As such, the discussion (and this review) of 
the relationship between spirituality and PTSD is often centered around moral injury and 
posttraumatic growth.  
Moral Injury. The moral injury literature is quickly expanding and warrants a 
larger discussion beyond the scope of this literature review. However, it is important to 
note that moral injury is a concept that is increasingly important in the veteran population 
(McGuigan, 2013). Moral injury can be defined as “enduring distress and alterations in 
functioning following events in which combatants perceive themselves to violate, 
through action or inaction, their own moral codes” (Nash et al., 2013, p. 647).  
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The Moral Injury Events Scale (MIES; Nash et al., 2013) is the most widely used 
measure of moral injury and has demonstrated strong psychometric properties, including 
multiple confirmatory factor analyses validating the proposed factor structure (Bryan et 
al., 2016). The link between moral injury and spirituality is strong in the conceptual 
literature (Kopacz et al., 2016), yet the MIES does not contain any questions explicitly 
addressing spirituality. As such, it is difficult to extrapolate the preliminary results from 
this scale to the assessment of spirituality in PTSD, especially given the lack of 
replication of initial findings at this time (Bryan et al., 2016).  
In the studies that have explicitly assessed the relationship between spirituality 
and PTSD in military populations, the results are mixed. Two recent studies of veterans 
(Currier, Holland, & Malott, 2015; Kopacz et al., 2016) found that high levels of 
spirituality appear to serve as a protective factor against PTSD and suicidality while 
struggles with spirituality are related to worse treatment outcomes. However, another 
study of veterans linked higher levels of spirituality to increased PTSD symptom 
severity, which, in the moral injury framework, is explained by the violation of closely 
held moral or spiritual beliefs by the experience of combat-related trauma (Hourani et al., 
2012). Given the stage of research for moral injury and the lack of research for 
spirituality, it appears as if it may be useful to continue assessing for moral injury in a 
veteran population, though it appears to be appropriate to reserve these measures for 
specific instances in which clinical judgement suggests an area of need.  
Posttraumatic Growth. As is the case for moral injury, an in-depth discussion of 
posttraumatic growth is beyond the scope of this review. With respect to PTSD, the 
conceptual literature is extensive, though the empirical evidence is mixed (Mancini, 
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Littleton, & Grills, 2016; Steenkamp et al., 2012). Posttraumatic growth is defined as “the 
experience of positive change that occurs as a result of the struggle with highly 
challenging life crises” (Tedeschi & Calhoun, 2004). It is most often measured using the 
Posttraumatic Growth Inventory (PTGI; Tedeschi & Calhoun, 1996), which has been 
shown to have adequate psychometric properties across a variety of studies, including 
successful confirmatory factor analyses of the originally proposed five-factor model 
(Ramos, Leal, Marôco, & Tedeschi, 2016). The five factors are: Relating to Others; New 
Possibilities; Personal Strength; Spiritual Change; and Appreciation of Life (Tedeschi & 
Calhoun, 2004). 
It is difficult to ascertain the strength of the literature for PTSD specifically, as 
much of this literature does not differentiate between trauma and PTSD (Mancini et al., 
2015). However, in the studies that have measured posttraumatic growth in PTSD 
populations, results are mixed. Bryant et al. (2016) found that, unlike the evidence from 
non-clinical trauma-exposed samples, PTSD results in ongoing functional impairment 
following symptom remittance. This is compounded by findings from Frazier et al. 
(2009) that, in a sample of undergraduates who experienced a traumatic event at some 
point over the course of a semester (n = 122), perceived posttraumatic growth (as 
measured by the PTGI) did not match measured PTSD symptom reduction and did not 
predict future PTSD symptom reduction. Similarly, in a sample of survivors of the 2011 
Oslo bombing, Blix et al. (2016) found that survivors with PTSD who reported early 
posttraumatic growth experienced greater PTSD symptoms long-term than those who did 
not report early posttraumatic growth. A large-scale analysis has not been conducted on 
posttraumatic growth, as the concept is still being refined and has not been rigorously 
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studied (Blix et al., 2016). There is cause for optimism, as a new update of the PTGI 
called the PTGI-X was developed to enhance the ability of the scale to assess spiritual 
change cross-culturally, and preliminary evidence suggests this updated scale has better 
sensitivity and factor analytic properties than the original scale (Tedeschi, Cann, Taku, 
Senol-Durak, & Calhoun, 2017). While this may change with more widespread use of 
this new scale, there appears to be a significant gap between the conceptual literature and 
the trends seen in the evidence, and as such, no strong conclusions about the relationship 
between posttraumatic growth, spirituality, and PTSD can be made at this time. 
Family Functioning  
The relationship between family functioning and PTSD is more straightforward 
than was the case for spirituality, though there are still several areas in need of further 
exploration. It has been widely established that PTSD is linked to acute and longitudinal 
impairments in martial and familial functioning in multiple populations, most notably in 
veterans, survivors of sexual assault, and refugees across the world (Bryant et al., 2016; 
Evans, Cowlishaw, & Hopwood, 2009; Silove, Ventevogel, & Rees, 2017; Vogt et al., 
2017). Specific areas of impairment include “poorer family adjustment, more relationship 
problems, more problems with intimacy, higher levels of relationship distress, more 
parental problems, lower family cohesiveness, and less constructive communication 
behaviors” (Vasterling et al., 2015, p. 150). The mechanisms of this relationship are 
unclear, with some positing that specific symptom clusters (most commonly numbing / 
avoidance) predict functional impairments (e.g., LeBlanc et al., 2016), others who 
propose family discord contributes to the development and maintenance of PTSD (Evans 
et al., 2009), and still others who conclude that the relationship is bidirectional (Vogt et 
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al., 2017). A definitive conclusion cannot be drawn given the state of the research 
evidence at this time. However, across populations, research supports the assertion that, 
for many people suffering from PTSD, assessing and treating familial functional 
impairments can lead to improved treatment outcomes (Evans et al., 2009; LeBlanc et al., 
2016; Rodriguez, Holowka, & Marx, 2012). As such, it is important to know best 
practices for family functioning measurement used in PTSD.   
Measuring the full range of the relationship between PTSD and family 
functioning is incredibly complex, as each family unit is a unique culture situated within 
a larger culture, the expectations and norms from which impact the specific course of 
functional outcomes (Silove et al., 2017; Vasterling et al., 2015). However, a general 
biopsychosocial assessment is recommended to determine if the client perceives family 
functioning to be an issue, after which specific measures can help clarify identified 
issues, as well as if family currently serves as a protective factor (Evans et al., 2009; 
Melchert, 2015). When conducting this assessment, it is important to include culturally-
specific functional measures, as “Failure to include indigenously derived measures that 
capture local expressions or idioms of distress also can lead to the under‐enumeration of 
mental health problems” (Silove et al., 2017, p. 137). 
 Examples of specific outcome measures that have demonstrated strong utility for 
PTSD include the Dyadic Adjustment Scale (DAS; Spanier, 1976), the Relationship 
Assessment Scale (Hendrick, 1988), and the Deployment Risk and Resilience Inventory-
2 (Vogt et al., 2013), which measures a range of perceptions of family discord and 
support. When assessing family functioning, it is crucial to obtain collateral information 
from family members instead of purely relying on self-report data (Rodriguez et al., 
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2012). Multi-dimensional, collaborative assessments such as the McMaster Family 
Assessment Device (Epstein et al., 1983) and the DAS have been shown to be especially 
effective in helping clinicians corroborate client reports of familial impairment and can 
easily be ported to a couples and family setting, should the focus of treatment shift to 
family functioning (Vasterling et al., 2015). Additionally, effective PTSD treatments 
(e.g., PE for PTSD, CPT) require work to be done in the home environment, and success 
in treatment may depend on the stability of the home and family relationships (Green et 
al., 2017). Finally, if someone has been abused by a member of their family, the quality 
of relationships with other family members and ability to forgive the person who abused 
them has been linked to improvements in PTSD symptoms, though balancing this finding 
with potential safety concerns is a clinical priority (Baldry, Cinquegrana, Regalia, & 
Crapolicchio, 2017).  
In sum, there appears to be an important relationship between PTSD and family 
functioning, though the directionality of this relationship is unclear. As such, in PTSD 
populations, it is important to include family functioning in a general biopsychosocial 
approach to understand the specific relationship between PTSD symptoms and family 
functioning in the individual. If problems are identified, assessments should be used to 
inform greatest treatment need, the evidence from which should be corroborated with 
data from family members obtained through assessment or clinical interview. If 
necessary, family therapy is indicated and can be an essential treatment component for 
people with PTSD experiencing familial impairment (Rodriguez et al., 2012; Vasterling 
et al., 2015; Vogt et al., 2017) 
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Interpersonal and Social Functioning  
Long-term social and interpersonal impairments are well-established in PTSD and 
are especially connected to avoidance and intrusion symptoms (Kashdan, Morina, & 
Priebe, 2009; Solomon & Mikulincer, 2007; Tsai, Harpaz-Rotem, Pietrzak, & Southwick, 
2012). Impairment in social functioning is a focal point in the cPTSD literature, though 
the previous focus on phase-based treatments beginning with building up social skills has 
not been shown to be effective in the literature (De Jongh et al., 2016; Rothbaum et al., 
2012). However, there is growing evidence that addressing interpersonal functioning and 
building interpersonal skills is an essential component of effective trauma treatment that 
can address symptoms of avoidance and reduce dropout rates (Eidhof et al., 2019; 
Markowitz et al., 2015). While the evidence is not strong enough to suggest interpersonal 
therapy or interpersonal skill building alone is a consistently effective PTSD treatment, 
focusing on interpersonal functioning is undeniably effective in increasing quality of life 
during and after treatment (Cloitre et al., 2005). 
There are many measures of interpersonal functioning that have been utilized in 
PTSD outcomes assessment (e.g., Inventory of Interpersonal Problems; Horowitz et al., 
1988) that are typically focused on perceived quality of interpersonal relationships. 
However, another perspective on interpersonal functioning in PTSD posits that 
transdiagnostic intimacy (Wetterneck & Hart, 2012) might be an especially effective 
treatment target, as people with PTSD tend to struggle to develop close and lasting 
relationships with others. People who have experienced repeated interpersonal trauma 
have an especially difficult time forming close bonds with others and are less likely to 
engage in interpersonal behaviors (e.g., being vulnerable in relationships) that promote 
48
feelings of connection with others (Bistricky et al., 2017; Eidhof et al., 2019). Assessing 
intimacy (defined here as emotional and interpersonal vulnerability with others) via 
measures such as the Awareness, Courage, and Love scale (Kuczynski, 2016) can help 
focus assessment and intervention on the ability to build meaningful relationships with 
others, which has been posited as a core process of change in PTSD, especially in cases 
with multiple comorbidities (Cloitre, 2015).  
 In addition to encouraging the development of close and meaningful relationships 
with safe others, it is helpful to understand how social networks and social support 
contribute to the development and maintenance of PTSD. The relationship of social 
connection to PTSD is complex, and often differs between populations. For instance, in 
military populations, there is evidence PTSD is associated with high levels of stigma, 
which is often seen in peers fearing and avoiding the soldier with PTSD (Sayers, Farrow, 
Ross, & Oslin, 2009; Sripada et al., 2015). This is particularly problematic in military 
populations, as the military culture often serves as both a crucial social support network 
and as a barrier to seeking help for mental health problems (Hoge et al., 2004; 
Michalopoulou, Welsh, Perkins, & Ormsby, 2017). However, research has consistently 
shown that non-military family and friends are not viewed as being particularly 
stigmatizing, and instead serve as supports for veterans with PTSD (Hamilton et al., 
2015; Hoge et al., 2004).  
Additionally, there is preliminary evidence that the perceptions of stigmatizing 
beliefs for seeking help for mental health issues within the military is decreasing. In a 
military sample (n = 601), Bein, Grau, Saunders, and deRoon-Cassini (2019) found that, 
while soldiers still perceive military peers, subordinates, and superiors to be more 
49
stigmatizing than non-military family and friends, the overall rates of perceived stigma 
were much lower than has been seen in previous literature. Additionally, soldiers reported 
seeking help at higher rates than had been seen in previous literature, which is consistent 
with other recent trends noted in new generations of veterans (Kulesza et al., 2015). This 
trend is encouraging and suggests the general finding that social support predicts more 
willingness to seek out and engage in PTSD treatment (Platt, Keyes, & Koenen, 2014) 
holds in military populations, especially given the observed decrease in perceived stigma 
from military others. Given the unique circumstances surrounding the military and social 
support, it appears to be best practice to tailor interviews with veterans to inquire as to 
sources of social support and perceived stigma from these sources (Hamilton et al., 
2015).  
 There are several other interesting findings concerning the relationship between 
social functioning and PTSD that are important to note and integrate into outcome 
assessment. It appears as if perceived social support is less important than having a 
diverse social network (i.e., engaging in multiple social groups with different people) in 
the development and maintenance of PTSD (Platt, Keyes, & Koenen, 2014). Findings 
were consistent across racial, ethnic, gender, and socioeconomic groups. However, these 
results are not consistent in the literature. A large epidemiological study assessing PTSD 
in non-Hispanic White, non-Hispanic Black, and Hispanic women in the United States 
(Lipsky, Kernic, Qiu, & Hasin, 2016) found that perceived social support inconsistently 
functions as a protective factor, but that diversity of social networks consistently predicts 
better treatment outcomes. In a meta-analysis from Brewin, Andrews, and Valentine 
(2000), the strongest predictor of PTSD development was lack of social support, and 
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analyses showed relative consistency between perceived social support and diversity of 
social networks. The importance of diverse social networks is also seen in recent study 
from Schnurr and Lunney (2016) in which CAPS rating of social impairment and not 
self-rated social functioning was related to the loss of a PTSD diagnosis.  
Taken together, these results suggest that perception of the quality of social 
functioning and engaging in a diverse range of social activities are potentially important 
areas of focus, which is an important nuance to note when assessing social functioning. 
Most of the studies reviewed utilized a variety of metrics to assess perceived social 
support, although the Interpersonal Support Evaluation List (ISEL12; Cohen et al., 2008), 
a self-report questionnaire that measures perceptions of the availability of social support, 
was used most commonly. Measuring social network diversity is typically achieved 
through use of the Social Network Index (Cohen et al., 2008), a self-report questionnaire 
that measures participation in 12 different types of social networks over the past two 
weeks. These measures have substantial evidence in support of their validity and 
reliability (Lipsky et al., 2016), and appear to appropriate measures for outcomes 
research. It is also important to keep track of new research designed to increase the 
availability for culturally-appropriate measures. One potential explanation for the lack of 
predictive power for perceived social support is the failure to measure culturally-specific 
forms of social and cultural support (Lipsky, Kernic, Qiu, & Hasin, 2016), which is 
problematic given the consistent usage of the ISEL12, which was used in all papers 
assessing social support in this review. For a PTSD program, it appears as if cross-
referencing any stand-alone social functioning measure with clinician-rated social 
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functioning on the CAPS is best practice, as there is research evidence in support of 
measuring both perceived social functioning and social network diversity. 
Occupational Functioning  
The literature surrounding occupational functioning in PTSD comprises two 
general areas: occupational impairment and assessing PTSD-related disability. In terms 
of the impact of PTSD, Breslau, Lucia, and Davis (2004) found that severity of PTSD 
was linked to work-loss days and lack of employment. These findings have been seen in 
multiple populations, so much so that occupational impairment is one of the potential 
functioning impairments listed in the DSM-5 (De Jongh et al., 2016). It has been 
suggested that focusing on increasing engagement in work-related activities can be 
beneficial for people with PTSD, which has minor support in the literature (Levers, 2012; 
Taylor, Wald, & Asmundson, 2006). However, evidence suggests that the best method to 
help patients increase occupational functioning is to decrease their symptom severity 
through evidence-based practice (Schnurr & Lunney, 2016).  
 Engaging in evidence-based practice is also the recommendation from the 
literature surrounding assessment of occupational impairment (McNally & Frueh, 2013), 
though for a slightly different reason. There is mounting evidence that, especially when 
seeking disability, large numbers of people may malinger PTSD symptoms (Hall & Hall, 
2007; McNally & Frueh, 2013; Messer & Fremouw, 2007). A brief discussion of 
malingering in PTSD can be found in a previous section of this review, including 
appropriate measures (e.g., DAPS, TSI, MENT-R, PAI, MMPI-2) to assess the validity of 
PTSD symptoms, specifically. Best practice literature indicates that at least one of these 
measures should be given during a diagnostic assessment, and ability to detect 
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malingering increases dramatically with the use of more than one validity measure 
(McNally & Frueh, 2013).  
While some have asserted that malingering is better explained by delayed onset 
PTSD (e.g., Marx et al., 2012), the evidence does not appear to support this claim. 
Instead, it is likely that making success of disability claims dependent on a PTSD 
diagnosis has increased the number of malingering cases (McNally & Frueh, 2013). 
Additionally, there is evidence that long-term psychiatric disability related to PTSD can 
be reversed through engagement in evidence-based practice (Marx et al., 2012) and, 
conversely, that disability payments were linked to lower outcomes of returning to work 
(Siminski, 2013). While this debate is not likely to be settled in the near future, it is 
evident that an accurate assessment of occupational functioning, especially when a 
potential disability claim is involved, should involve validity measures. Finally, with the 
intention of improving functional outcomes, recommending engagement in ESTs for all 
people diagnosed with PTSD, regardless of disability claim, is indicated.  
Physical Functioning  
Across military, civilian, and refugee populations, PTSD is linked to impairments 
in physical functioning and an increase in the likelihood of greater healthcare utilization, 
healthcare costs, chronic illness (e.g., fibromyalgia, cardiovascular disease, stroke, and 
obesity), prescription medication misuse, and decreased involvement in physical activity 
(Agorastos et al., 2014; McFarlane, 2010; Steinert, Hofmann, Leichsenring, & Kruse, 
2015; Trost et al., 2015; Zatzick et al., 1997). The consistency of the negative health-
related impacts of PTSD is particularly concerning, because despite the well-established 
finding that PTSD is linked to negative health outcomes, there is little long-term outcome 
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research that addresses the relationship between engaging in PTSD treatment and 
physical health outcomes (Steinert et al., 2015). However, there are several relationships 
that have been explored in the literature. First, research suggests that untreated pain and 
physical health problem severity is linked to the development and exacerbation of PTSD, 
especially when the trauma involves a physical component (e.g., interpersonal violence, 
workplace injury, mild traumatic brain injury; Archer et al., 2016; Hoge & Engel, 2008). 
Simultaneously, a challenging trend seen in the development of physical health issues 
after trauma is a gradual increase in physical health symptom severity that does not match 
the emergence of PTSD symptomology (Murphy & Busuttil, 2015).  
An increasingly accepted explanation of this trend is the cumulative effect of 
stress on the HPA-axis and autonomic nervous system, which is known as “allostatic 
load” (McFarlane, 2010). Allostatic load has been proposed as one of the most important 
concepts for understanding the relationship between PTSD and physical health, as 
previous theories suggesting that health-related behaviors (e.g., smoking, drug use, and 
poor exercise) explain this relationship have not been supported in the literature 
(Shipherd, Clum, Suvak, & Resick, 2014). Additionally, the literature has shown the 
relationship between allostatic load and PTSD is not mediated by health-related 
behaviors (Agorastos et al., 2014). Appropriate measurement of allostatic load is well-
established, though it requires access to medical testing and diagnostics. Specifically, 
allostatic load is measured through analyzing nine indicators obtained via a blood test and 
medical examination including systolic blood pressure, C-reactive protein, and Albumin 
levels (Shipherd et al., 2014).  
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While the relationship between allostatic load and PTSD is relatively clear, 
allostatic load is rarely assessed, especially in the context of outcomes research 
(McFarlane, 2010). Currently, there is almost no data focused on the relationship between 
PTSD treatment engagement and allostatic load. Instead, there is considerable evidence 
that engaging in evidence-based PTSD treatment, especially PE for PTSD, leads to 
increased HRQoL, specifically general health perceptions, physical role functioning, and 
bodily pain (Dolezal, Lum, Bentley, & Zoellner, 2018; Pagotto et al., 2015). In the 
literature, HRQoL is most often assessed using the Short-Form Health Survey (SF-36; 
Ware & Sherbourne, 1992), which has considerable evidence in terms of reliability and 
validity (Pittman et al., 2012) However, from the little data available concerning the long-
term ability of PTSD treatment to increase HRQoL, it does not appear that improvements 
are maintained post-treatment (Dolezal et al., 2018). As such, as has been suggested in 
other measurement domains in this review, it appears to be crucial to assess long-term 
outcomes to determine if current treatment modalities have HRQoL benefit after 
treatment. In settings able to complete medical testing, it appears as if measuring 
allostatic load in conjunction with HRQoL at pre-treatment, post-treatment, and follow-
up can provide valuable insight into the ability of PTSD treatment to impact the 
relationships seen in the literature. 
Well-being & Quality of Life 
The sections of this review on spiritual functioning (including moral injury and 
posttraumatic growth), interpersonal and social functioning, occupational functioning, 
and physical functioning comprise most of the component evidence for quality of life. 
Additionally, in many ways, these sections provide the building blocks for understanding 
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quality of life and well-being, as the concepts are intrinsically linked conceptually and in 
the specific domains they assess (Zatzick et al., 1997). In fact, there is considerable 
debate concerning the benefits of separately measuring well-being and quality of life, 
with the consensus being that due to large overlap between the constructs, it is most 
beneficial to create robust measures that assess domains germane to both constructs 
(Medvedev & Landhuis, 2018). This followed a long-standing divide between measures 
of well-being and quality of life that began to converge after the following definition was 
proposed: “The theoretical formulation of well-being was thus supported as a 
multifaceted domain encompassing positive self-regard, mastery of the surrounding 
environment, quality relations with others, continued growth and development, 
purposeful living, and the capacity for self-determination” (Ryff & Keyes, 1995, p.724). 
The extent of this debate is too broad to cover in this review, yet the combination of well-
being and quality of life into a larger, comprehensive metric is notable. 
A large survey-based study (n = 2533) conducted using data from 11 countries 
from Skevington and Böhnke (2018) assessed the relationship between subjective well-
being and quality of life using the World Health Organization Quality of Life measure 
assessing Spirituality, Religious, and Personal Beliefs (Skevington, Gunson, & 
O’Connell, 2013). Analyses suggested the benefit of combining subjective well-being 
and quality of life into a single, larger metric that does explicitly focus on subjective 
well-being. The areas discussed in the sections above, including physical health, social 
support, familial functioning, spirituality, and resilience, are all represented conceptually, 
suggesting the benefit of assessing quality of life via the best practice assessments 
discussed in the previous sections or using a larger, comprehensive metric.  
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Processes of Well-being in PTSD 
When viewed through the process-based lens discussed earlier in this review, the 
relationship between quality of life and PTSD becomes slightly less clear than might be 
indicated in the literature. Quality of life is conceptualized as an outcome or outcomes 
rather than a process or processes (Howgego et al., 2005). While previous research has 
shown the ability of PTSD treatment, specifically PE for PTSD, to improve quality of life 
(Dolezal et al., 2018), the processes by which this improvement is achieved are not as 
well understood. One biological process, allostatic load, has already been shown to be a 
potentially important moderating variable in the relationship between PTSD and quality 
of life, and current research on quality of life has been focused on identifying mediating 
and moderating variables to explain the relationship between treatments for DSM 
disorders and quality of life (Gu, Strauss, Bond, & Cavanagh, 2015). In PTSD, this area 
of research is relatively new, and there is still a substantial amount of work that needs to 
be done to make any strong conclusions. However, evidence does exist that several 
psychological processes are important mechanisms of change in PTSD outside of 
symptom severity. These processes with the most empirical support in the literature are: 
mindful awareness, compassion, emotion regulation, acceptance, and psychological 
flexibility. These processes, when targeted in conjunction with empirically supported 
treatments focused on symptom reduction (e.g., PE for PTSD, CPT), can facilitate 
improved quality of life beyond the effect of empirically supported treatments alone 
(Boyd, Lanius, & McKinnon, 2018; Gu et al., 2015; Gratz & Tull; Hoffart, Øktedalen, & 
Langkaas, 2015; Kashdan et al, 2009). It is important to note that more research is 
necessary to tease apart these processes of change, as core exercises (e.g., mindfulness 
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meditation) involve the cultivation of multiple processes. In the following sections, the 
evidence in support of these processes will be reviewed. 
Psychological Inflexibility and Experiential Avoidance  
The psychological flexibility model, proposed by Hayes, Strosahl, and Wilson 
(1999), is the foundation for Acceptance and Commitment Therapy. The model includes 
six core processes: “(1) cognitive fusion / defusion, (2) experiential avoidance / 
acceptance, (3) loss of flexible contact with the now / present moment focus, (4) 
attachment to a conceptualized self/ self as context, (5) values problems / chosen values, 
and (6) inaction, impulsivity, or avoidant persistence / committed action” (Levin et al., 
2012, p. 5). In this theoretical model, each of these core processes contribute to the 
construct of psychological flexibility. 
Overall, the evidence for the utility of the AAQ-II, the main measure used to 
assess psychological inflexibility (the opposite of psychological flexibility), is strong. 
Psychological inflexibility (as measured by the AAQ-II) has been shown to mediate the 
relationship between trauma exposure and PTSD symptom severity in prolonged 
childhood abuse (Shenk et al., 2014), veterans (Meyer et al., 2018), and refugees 
(Kashdan et al., 2009). However, there is considerable concern about the construct 
validity of the AAQ-II, although these concerns focus on the assertion that the AAQ-II 
measures psychological inflexibility, as opposed to the assertion that it measures 
acceptance versus experiential avoidance (Rochefort, Baldwin, & Chmielewski, 2018; 
Wolgast, 2014). Experiential avoidance can be defined as “an unwillingness to 
experience psychological events even when attempts to escape of avoid such events have 
caused behavioral harm” (Hayes, Wilson, Gifford, Follette, & Strosahl, 1996, p. 1158). 
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Specifically, it is unclear if the AAQ-II is an appropriate measure of psychological 
flexibility vs. experiential avoidance, or if it is a measure of acceptance vs. experiential 
avoidance (Gloster, Klotsche, Chaker, Hummel, & Hoyer, 2011). This confusion can be 
seen throughout the literature, with some studies referring to the AAQ-II as measuring 
acceptance (e.g., Kotsou, Leys, & Fossion, 2018), and others referring to the AAQ-II as 
measuring psychological flexibility (e.g., Meyer et al., 2018). This is an issue that 
requires additional convergent and divergent validity research. 
One example of research in this vein is a meta-analysis from Levin et al. (2012) in 
which 66 component analyses were evaluated. Results were favorable for the overall 
construct of psychological inflexibility, though a component analysis revealed a large 
effect size for acceptance and medium to large effect sizes for cognitive defusion, values, 
and present moment components. As such, it appears to be most helpful to assess these 
constructs both individually and in relation to one another. In the PTSD literature, there is 
substantial support for acceptance, defusion, and present moment awareness as processes 
of well-being, and the evidence for each will be discussed in the following subsections. 
Because there is ample evidence that the AAQ-II measures experiential avoidance, 
acceptance, and aspects of valued living (Gloster et al., 2011; Meyer et al., 2018), which 
are all components of the psychological flexibility model, it appears acceptable to view 
the AAQ-II as a measure of psychological flexibility (with a strong emphasis on the 
acceptance component) vs. psychological inflexibility. 
Acceptance vs. Experiential Avoidance. Experiential avoidance is thought of as 
being central to the development and maintenance of many DSM disorders, including 
PTSD (Orsillo & Batten, 2005). As has been emphasized in this review, the problem of 
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comorbidity in PTSD treatment is still central in the development of effective treatments. 
What is important to note about experiential avoidance is that is has been shown to be a 
core process in the development and maintenance of the most common comorbid 
disorders for PTSD, including personality disorders (Iverson et al., 2012), substance use 
disorders (Levin et al., 2012), panic disorder (Barlow, 2014), social anxiety disorder 
(Kashdan et al, 2009), and major depressive disorder (Spinhoven et al., 2016). As such, 
experiential avoidance appears to be a transdiagnostic process that, if targeted effectively, 
can address PTSD and comorbid disorders simultaneously.  
In PTSD specifically, the avoidance of distressing thoughts through attempted 
thought suppression, the avoidance of trauma-related reminders via physical avoidance, 
and the avoidance of distressing emotions via numbing are all central factors that 
contribute to the development and maintenance of PTSD (Orsillo & Batten, 2005; Powers 
et al., 2010). Exposure-based treatments for PTSD are centered around the concept of re-
engaging with previously avoided stimuli in a safe context, especially those that have 
become trauma-related (Green et al., 2017). It has been proposed that CPT and PE for 
PTSD, the two PTSD treatments with the strongest evidence base, are both addressing 
EA, albeit through different approaches (Green et al., 2017). CPT addresses experiential 
avoidance by way of changing posttraumatic cognitions and PE for PTSD addresses it by 
way of in vivo and imaginal exposure. As has been discussed in this review, the evidence 
base favors PE for PTSD by a narrow margin. However, the evidence suggesting 
experiential avoidance as a shared mechanism of change between treatments begs the 
question: How can treatments for PTSD actively target experiential avoidance? Given the 
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conceptualization of acceptance and experiential avoidance as opposite ends of a 
spectrum, one answer appears to be an explicit focus on acceptance in psychotherapy. 
When behaviorally defined, acceptance is “approaching (often distressing) 
psychological events and related situations, without trying to change, avoid, suppress, 
escape from, or prolong them” (Forsyth & Ritzert, 2018, p. 663). PE for PTSD and CPT 
explicitly target the reduction of experiential avoidance and both treatment approaches 
indirectly target acceptance of trauma-related cognitions, emotions, and reminders 
(Vujanovic et al., 2009). The process of a patient accepting, rather than approving of, 
their trauma has been linked to an increase in quality of life after engaging in evidence-
based trauma treatment (Cloitre, 2015; Harned et al., 2014; Walser, 2006). Preliminary 
trials of ACT for PTSD (e.g., Land, 2010; Orsillo & Batten, 2005), which explicitly 
targets acceptance, have suggested the benefit of accepting internal events and treating 
experiential avoidance through the cultivation of acceptance and movement towards 
values. One of the proposed benefits of this approach is increased treatment adherence 
and lowered dropout rates (Land, 2010), which is a problem in all treatments for PTSD 
(Ehring et al., 2014). The evidence suggesting ACT as a comprehensive intervention for 
PTSD is incomplete, though growing (Bluett, 2017). However, the evidence supporting 
the role of core processes of change in ACT, including acceptance, is strong. As such, the 
combination of intentional acceptance and engagement in exposure-based treatment for 
PTSD appears to provide an avenue to address EA in a more robust manner than has been 
seen in manualized treatment alone. 
It should be noted that acceptance is viewed as a behavioral skill that requires 
practice (Forsyth & Ritzert, 2018). The most common method to practice acceptance is 
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through mindfulness meditation, though experiential activities from the ACT literature 
have shown promising preliminary results (Hayes & Hofmann, 2018). Consistently, 
mindfulness meditation shows robust effects on the increase of acceptance. For example, 
in a recent study from Boyd, Lanius, and McKinnon (2018) even a novice meditator 
showed small to medium effect sizes increases in acceptance of distressing mental events. 
It is important to note that evidence suggests a specific, validated measure of acceptance 
and related constructs such as the AAQ-II might be better at measuring acceptance than a 
measure designed to assess mindfulness such as the Mindful Attention and Awareness 
Scale (MAAS; Brown & Ryan, 2003; Boyd et al., 2018). However, this is not a long-term 
solution for measuring acceptance, as the AAQ-II has been suggested as best measuring 
psychological inflexibility (Ong, Pierce, Woods, Twohig, & Levin, 2019). 
Clinically, there is some evidence that group therapy with sessions explicitly 
focused on acceptance (e.g., DBT or ACT groups) can help to build acceptance skills 
(Becker & Zayfert, 2001; Harned et al., 2014). Finally, a core focus on acceptance as a 
healing process appears to be effective across cultures, including in non-Western cultures 
in which the validity of the PTSD construct has been hotly debated (Hinton, Pich, 
Hofmann, & Otto, 2013; Marsella, 2010). Ultimately, it appears as if acceptance is a 
potentially important process of change in PTSD, especially with respect to quality of 
life. In treatment, it also appears as if dedicating time towards building acceptance and 
psychological flexibility skills through mindfulness mediation and assessing those skills 




Present-moment Awareness  
While mindfulness meditation can facilitate an increase in acceptance, there is 
also evidence that mindfulness awareness, or attention flexibility, is an essential process 
of wellness in PTSD. In a systematic review of mindfulness-based interventions for 
PTSD, Boyd et al. (2018) found medium to large effect size increases in attentional 
control and HRQoL that coincide with decreases in PTSD symptom severity. This may 
be partially due to a lack of component analysis of mindfulness measures, yet the current 
literature clearly supports the benefits of increased attentional control in PTSD. In both 
PTSD and depression, the combination of mindful awareness and acting with awareness 
is linked to decreased rumination and increased quality of life (Costa, Gouveia, & 
Marôco, 2018, Land, 2010; Levin et al., 2012). These findings are corroborated by 
emerging neurobiological evidence that engagement in mindfulness meditation and 
acting with mindful awareness modulates limbic system activation in PTSD patients, 
which is linked to a decrease in anhedonia and externalizing behaviors and an increased 
ability to effectively engage in PE for PTSD (Boyd et al., 2018; Fonzo et al., 2017). 
Additionally, engaging in mindfulness meditation has been shown to decrease 
alexithymia in PTSD patients by way of increasing right insula cortical thickness, which 
is correlated with greater emotional awareness and regulation (Lanius et al., 2015). This 
may be the most encouraging finding regarding mindful awareness, as people with PTSD 
typically have a great deal of difficulty identifying and engaging with difficult emotions, 
and alexithymia is a negative prognostic factor for treatment (Twohig, 2009).  
Many measures include components of mindfulness, including the AAQ-II. A 
systematic review of mindfulness instruments from Park, Reilly-Spong, and Gross (2013) 
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assessed 46 articles that evaluated 10 different mindfulness measure. Their analysis was 
conducted using the Consensus-based Standards for the Selection of Health Status 
Measurement Instruments checklist, which assesses reliability, validity, and 
responsiveness. From this strong methodological framework, the review found that the 
MAAS (Brown & Ryan, 2003) had the strongest evidence base, but that additional 
research is needed on all instruments reviewed, especially factor analytic and convergent 
validity evidence. As such, in a PTSD outcomes program, it appears to be best practice to 
perform confirmatory factor analysis on any mindfulness scale administered, which is in 
conjunction with best-practice statistical recommendations (Chan, 2009). Measurement 
of neurobiological changes is beyond the abilities of most outcomes research programs, 
yet this evidence (present and future) is important to note for any PTSD outcomes 
research program.  
Cognitive Fusion and Rumination  
Two constructs that are closely related but purport to measure distinct processes 
are cognitive fusion and rumination. Cognitive fusion occurs when “a person acts on 
thoughts as though they are literally true, cognitive events come to dominate behavior 
and experience over other sources of behavioral regulation, and he or she becomes less 
sensitive to direct consequences” (Gillanders et al., 2014, p. 84). Much like the 
relationship between experiential avoidance and acceptance, cognitive fusion is thought 
of as being on one end of a spectrum with cognitive defusion, or “unhooking” oneself 
from the belief that cognitive events are literally true representing the other end (Levin et 
al., 2012). Cognitive fusion is most often measured using the Cognitive Fusion 
Questionnaire (Gillanders et al., 2014), which has demonstrated strong reliability, 
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validity, and factor analytic properties across treatment populations (Bardeen & Fergus, 
2016; Nieuwsma et al., 2015). The definition of rumination, a related, yet theoretically 
distinct construct, is typically based on the Response Style Theory (RST; Nolen-
Hoeksema, 1991), which defines rumination as repetitively thinking about the causes, 
consequences, and symptoms of a person’s negative affect. This model is widely used 
throughout the literature, though it has mixed empirical support and, in some studies 
(e.g., Smith & Alloy, 2009), has been found to have poor stability and discriminant 
validity with measures of depression or anxiety. In PTSD, rumination is thought to fall 
under the symptom cluster of “negative alterations in cognitions and mood” and is often 
assessed using the IES-R or factor analytically using the PCL-5 (Armour et al., 2015; 
Green et al., 2017; Smith & Alloy, 2009). Cognitive fusion is distinguishable from 
rumination in that the focus is on the relationship to mental events rather than the 
repetition of those events. The initial scale analysis supported this distinction and found 
that cognitive fusion added additional variance above and beyond rumination in several 
large community samples (Gillanders et al., 2014). 
Targeting both cognitive fusion and rumination has been shown to decrease PTSD 
symptom severity and increase quality of life (Bardeen & Fergus, 2016; Green et al., 
2017; Jones, 2016), and both constructs have been suggested as core processes that 
influence the maintenance and development of PTSD (Ehring et al., 2014; Walser, 2006). 
What is currently unclear in the literature is how these two constructs interact with 
respect to PTSD, specifically. There is evidence that in PTSD, only specific types of 
rumination (e.g., focusing on how the trauma shapes one’s identity) significantly impact 
the development and maintenance of negative cognitive alterations in PTSD (Bardeen & 
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Fergus, 2016), which is conceptually linked to the fusion of self-concept with the impacts 
of trauma seen in cognitive fusion models (Boals & Murrell, 2016). However, this 
evidence base is just beginning to take shape, especially in PTSD. In depression, there is 
growing evidence that cognitive fusion, while related to rumination, should be a central 
target in treatment due to the unique ability of cognitive defusion to decrease depressive 
symptoms beyond typical cognitive restructuring methods (e.g., thought challenging; 
Costa et al., 2018). Even these results are preliminary, and the evidence in support of 
explicitly changing cognitions, not necessarily the relationship to those cognitions, in 
PTSD is uniquely strong (Green et al., 2017; McLean et al., 2015). More research is 
necessary to determine the relationship between rumination and cognitive fusion in 
PTSD, especially because decreases in both cognitive fusion and rumination have been 
linked to decreases in PTSD symptoms and quality of life. It appears to be important to 
replicate the model from McLean et al.’s (2015) study of cognitive fusion, rumination, 
and depressive symptomology. Translated to PTSD, this design allows the mechanisms 
of change (changing trauma-related thoughts vs. changing relationships to trauma-related 
thoughts) to be elucidated. 
Emotion Regulation 
Another proposed mechanism of change in PTSD, emotion regulation, has a large 
amount of evidence in support of its transdiagnostic validity. Specifically, emotion 
regulation has been shown to underlie psychological distress in substance use, 
depression, generalized anxiety disorder, personality disorders, and PTSD (Barlow, 2014; 
Gratz & Tull, 2010; Hayes & Hofmann, 2018; Hofmann & Barlow, 2014). Additionally, 
there is meta-analytic neurobiological evidence that engaging in ESTs, including PE for 
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PTSD, inhibits emotional reactivity via the amygdala and the specific cortical regions 
involved with emotion regulation (Frank et al., 2014; Hofmann & Barlow, 2014; Yehuda 
et al., 2015). Exposure-based treatments are especially effective at addressing emotion 
regulation, as the movement towards willingly tolerating distressing emotions builds up 
emotion regulation skills behaviorally and neurobiologically (Frank et al., 2014; Gratz & 
Tull, 2010; Yehuda et al., 2015). 
In a recent study from Cox, Motl, Bakker, & Lunt (2018), a meditation model 
found that addressing emotion regulation allowed for cognitive defusion in a veteran 
sample with PTSD. This in turn led to PTSD symptom reduction and increased quality of 
life (as measured by life satisfaction). This study utilized the PCL-5, the CFQ, and the 
Difficulties with Emotion Regulation Scale (Gratz & Roemer, 2004), which is a 
commonly used measure of emotion regulation with strong validity and reliability 
evidence (Cox et al., 2018). The study re-evaluated each scale for internal consistency in 
their sample, which adds strength to the findings. The results mirror findings from Gratz 
and Tull (2010) that suggest emotion regulation is a key process that contributes to the 
success of mindfulness and acceptance-based interventions. Additionally, while engaging 
in exposure-based PTSD treatments improve emotion regulation skills, populations with 
more severe emotion regulation difficulties (e.g., patients with personality disorders) 
have been shown to benefit from modified PTSD treatment protocols with an increased 
focus on building up emotion regulation skills such as DBT and ACT (Harned et al., 
2014; Shenk et al., 2014). As such, it appears as if emotion regulation is a core process of 
well-being in PTSD that can be targeted by ESTs and adjunctive treatment approaches 
(e.g., DBT & ACT).  
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Compassion and Shame  
The final proposed process of well-being in PTSD is compassion. Compassion 
can be viewed as one end of a spectrum with the other end being shame (Gilbert et al., 
2017). Compassion research in PTSD is almost uniformly focused on self-compassion, 
and most of this section of the review will focus on this research. However, it is helpful 
to note that compassion has also been conceptualized as a tri-fold flow consisting of 
compassion towards others, compassion towards self, and receiving compassion from 
others (Gilbert, 2010). This conceptualization of compassion is measured through the 
Compassionate Engagement and Action Scales for Self and Others (Gilbert et al., 2017). 
Theoretically, this approach to measuring compassion has great utility in PTSD, as 
people with PTSD typically have difficulty feeling connected to self and others (Foa et 
al., 2008), which would likely lead to deficits in all areas measured by the scale. 
Additionally, as has been discussed previously in this review, strengthening and 
broadening social support networks and reducing emotional avoidance is linked to 
increased quality of life, so targeting feelings of connection with self and others via 
compassionate meditation and experiential exercises, as is the approach in compassion-
focused therapy (CFT; Gilbert et al., 2017), would theoretically increase quality of life in 
people with PTSD. However, the only aspect of compassion with significant research 
evidence in PTSD populations is self-compassion, which will be discussed in the 
following paragraphs. 
To understand self-compassion’s role as a process of improving well-being in 
PTSD, it is helpful to explore the ways in which shame impacts PTSD development and 
maintenance. Shame is defined as the belief that one’s identity is flawed, wrong, or 
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broken (Lee, Scragg, & Turner, 2001). Shame is a particularly important construct for 
treatment conceptualization (and part of the diagnostic criteria for PTSD), as high levels 
of shame has been linked to decreased engagement in therapy and reticence to disclose 
trauma-related cognitions to the treating therapist (Jones, 2016; Steinmetz, Gray, & 
Clapp, 2019). As a result, failure to address shame has been generally linked to treatment 
failure across modalities and populations, even more than peri-traumatic fear, which was 
long seen as the greatest predictor of dropout (Crocker, Haller, Norman, & Angkaw, 
2016; Green et al., 2017). This is an especially relevant issue in military and civilian 
populations, as returning veterans who exhibit strong endorsement of traditional gender 
norms and people who have experienced sexual assault are two populations with the 
highest likelihood of developing trauma-related shame (Beks, 2016; Cloitre, 2015; 
Harned et al., 2014).  
In mediation studies, shame has been linked to decreased quality of life, including 
poorer social, physical health, and occupational domains (Au et al., 2017; Badour, 
Resnick, & Kilpatrick, 2017). Additionally, shame has been linked to the development of 
EA in PTSD, especially with respect to avoidance of difficult emotions (Gratz & Tull, 
2010). It has been suggested that the explicit targeting of shame in CPT leads to increased 
emotion regulation, which may be the primary mechanism by which the treatment 
approach is efficacious (Yehuda et al., 2015). However, there is also evidence that PE for 
PTSD can reduce shame across a wide range of traumatic exposures and civilian, 
military, and refugee populations (Crumlish & O’Rourke, 2010; Langkaas et al., 2017), 
which again suggests the possibility that reducing experiential avoidance of difficult 
emotions is a core process of change in evidence-based therapies for PTSD. However, 
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this evidence is preliminary, and is not as strong in survivors who have experienced 
multiple traumas or prolonged interpersonal trauma (Cloitre, 2015). Conceptually, it has 
been suggested that shame replaces a previously positive identity with a shame-based 
identity (Lee et al., 2001), and in subsequent traumas, activates and reinforces those 
maladaptive schematic representations of self (Au et al., 2017). These shame-based 
schemas are exceptionally difficult to target, and there is no consensus concerning the 
most effective way to target shame across disorders, including PTSD (Au et al., 2017).  
Different measures of shame are common in the literature, although several self-
report questionnaires are commonly used in PTSD, specifically: The Internalized Shame 
Scale (ISS; Cook & Coccimiglio, 2001), and the Experiences of Shame Scale (ESS; 
Andrews, Qian, & Valentine, 2002). In a meta-analysis from Saraiya and Lopez-Castro 
(2016), these measures were shown to have strong reliability and validity evidence, 
although treatment approaches addressing shame remained unclear. An alternative 
measure that may be helpful in assessing shame and other schematic representations of 
self is the Young Schema Questionnaire (YSQ; Schmidt, Joiner Jr., Young, & Telch, 
1995). Originally developed by Young (1991) to assess early maladaptive schemas in 
depression and borderline personality disorder, there is a growing evidence base that the 
YSQ (which has strong evidence in support of its reliability and validity) allows for the 
identification of numerous important schematic representations of self in PTSD, 
including shame-based schemas (Karatzias et al., 2016; Taylor, Bee, & Haddock, 2017). 
This may be a helpful alternative to a strictly shame-focused measure, as a more broad-
based assessment of maladaptive schemas can help tailor treatment (including treatment 
for shame) to the client’s unique negative alterations in cognition.  
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Self-compassion. Self-compassion is measured using the Self-Compassion Scale 
(SCS; Neff, 2003), which also exists in a short form (SCS-SF; Raes, Pommier, Neff, & 
Van Gucht, 2011). While there is considerable debate concerning the appropriate factor 
analytic structure of the SCS (e.g., Neff, 2016), the psychometric properties of the scale 
have been replicated numerous times in international samples (Au et al., 2017), the 
findings from which have also been replicated in PTSD populations (Hoffart et al., 2015). 
Ultimately, as it the case for most scales, it appears to be vitally important to test the 
factor analytic structure of the scale in the specific population in which analysis takes 
place, as no definitive conclusions concerning the factor structure has been reached. 
The evidence in support of cultivating self-compassion as a core process of well-
being in PTSD is growing, though incomplete. In a review of the self-compassion 
literature, Au et al. (2017) found medium to large effect size reductions following 
compassion-focused interventions (e.g., loving-kindness meditation and compassionate 
mind training). This study also assessed the ability of a six-week compassion-focused 
intervention (i.e., combining elements of compassionate mind training and loving-
kindness meditation) to reduce PTSD symptom severity. The study was well-designed 
and assessed PTSD symptom severity (as measured by the PCL-5), self-compassion (as 
measured by the SCS) and shame (as measured by the ISS) weekly, starting at baseline 
(baseline was randomized to two, four, or six-weeks). Importantly, follow-up data was 
also collected. The effect size reductions in PTSD symptom severity (Cohen’s d = 1.10) 
and shame were large (Cohen’s d = 1.03), as were increases in self-compassion (Cohen’s 
d = 1.46). While these large effect sizes are encouraging, the follow-up data suggests 
these gains were not only maintained but improved upon. Additionally, this study 
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experienced a very low dropout rate, and the rated acceptability of the interventions was 
high. These findings mirror those of Thompson and Waltz (2008), Dahm et al. (2015), 
Kearney et al. (2013), and Hoffart et al. (2015), who have all found medium to large 
effect size decreases in PTSD symptom severity (and, when measured, shame) that 
coincide with medium to large effect size increases in self-compassion following 
treatment programs either exclusively focused on self-compassion or for PE for PTSD 
augmented by compassion-focused exercises.  
The limitations of this line of research are, in some ways, reflective of the 
limitations of process-based research in PTSD. Many studies (e.g., Au et al., 2017) are 
preliminary examinations, meaning they have small sample sizes, are primarily 
conducted with participants who are White and female or male veterans, and exclude 
participants with comorbidities. Only a few studies (e.g., Hoffart et al., 2015) have 
examined the impact of cultivating self-compassion while concurrently engaging in an 
evidence-based treatment program for PTSD. These limitations (as well as the noted 
cautious optimism regarding study findings) have been reiterated in recent reviews of the 
role of self-compassion in PTSD treatment (e.g., Braehler & Neff, 2020; Winders, 
Murphy, Looney, & O'Reilly, 2020). Additionally, recent evidence has shown that self-
compassion might be a more important treatment target in cPTSD than in non-cPTSD 
(Karatzias et al., 2019) due to the presence of disturbances of self in cPTSD. According 
to this new research, self-compassion’s role in PTSD treatment may be helping those 
patients who have experienced complex, repeated trauma develop a kind and caring 
relationship with the self, which can offset this population’s oft-reported experience of 
unstable identity. These results are preliminary, yet promising. As such, the 
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preponderance of the evidence suggests cultivating self-compassion in PTSD could be a 
core process of well-being, especially for those with high levels of shame or identity 
disturbances. However, given the lack of evidence from active treatment programs, it is 
difficult to make any definitive conclusions. 
Gaps in Process-based PTSD Research  
Currently, it is unclear how these processes of well-being are interrelated in 
PTSD, as mediation studies that assess multiple process measures have produced 
contradictory results. Acceptance has been found to mediate the relationship between 
PTSD symptoms and both emotion regulation and present-moment awareness (Kotsuo, 
Leys, & Fossion, 2018). Emotion regulation has been found to mediate the relationship 
between PTSD symptoms (and to a lesser extent, quality of life) and cognitive fusion 
(Cox et al., 2018). Experiential avoidance has been found to mediate the relationship 
between PTSD symptom severity (and to a lesser extent, quality of life), emotion 
regulation (Shi, Zhang, Zhang, Fu, & Wang, 2016), self-compassion (Seligowski, Miron, 
& Orcutt, 2015) and cognitive fusion (Jones, 2016). This research is even more limited in 
treatment-seeking individuals with a PTSD diagnosis. To our knowledge, only one study 
(Grau, McDonald, Clark, & Wetterneck, 2020) has explored the relationship between 
experiential avoidance, cognitive fusion, and valued living in this type of sample, finding 
that experiential avoidance was a more robust predictor of admission PTSD symptom 
severity than cognitive fusion and valued living.  
Adding to the confusion is the theoretical connection between the discussed 
processes of well-being in PTSD. For example, it has been suggested that cultivating self-
compassion positively impacts emotion regulation (Neff & Dahm, 2015), which has been 
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posited to improve the ability to contact the present moment (Au et al., 2017), although 
mindfulness is also a core component of self-compassion (Neff, 2003). Additionally, 
cultivating self-compassion has been suggested as a process that can help increase the 
efficacy of cognitive defusion exercises by allowing patients to approach difficult 
thoughts mindfully and with a sense of shared human experience of suffering (Jones, 
2016).  
This may be a measurement issue in the current literature yet is it perfectly 
plausible that these processes are all uniquely helpful in facilitating the reduction of 
PTSD symptoms while improving quality of life. Examining ways in which multiple 
processes can be targeted at once and measuring the processes according to the best 
practice guidelines discussed in this review would likely be helpful and has been 
suggested by process-based researchers (e.g., Hayes & Hofmann, 2018). Augmenting 
traditional ESTs to explicitly target these processes and measuring how these processes 
interact to contribute increases in quality of life and decreases in PTSD symptom severity 
in these types of programs (e.g., PE for PTSD + DBT, ACT, or CFT) appears to be the 
best way to reach that goal.  
Integration 
 
Over the course of this review, best practice recommendations for engaging in 
PTSD outcomes research have been analyzed and discussed. Due to the heterogeneity of 
PTSD risk factors, development, and course, more research is needed in all areas, 
especially with traditionally underserved and underrepresented populations (e.g., REM 
clients). However, there are several strong lines of evidence with respect to symptom 
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severity reduction, quality of life, and processes of wellness that have emerged from this 
literature review.  
The ability to focus on well-being and improving patient functional outcomes is 
particularly important in treatment for patients with complex, repeated trauma. For these 
patients, the experience of trauma does not appear to be fully captured by the symptom 
checklists available for PTSD. Effective outcomes research must move beyond measures 
of symptom reduction and assess quality of life across multiple domains. However, 
symptom reduction is still an essential component of treatment, and there is a substantial 
(and ever-growing) evidence base with respect to the most effective approaches to 
treating PTSD. Based on this review, it appears that ESTs, especially PE for PTSD and 
CPT, are best able to reduce all clusters of PTSD symptoms, with PE for PTSD having 
slightly stronger evidence with respect to long-term outcomes than CPT. Overall, despite 
some variant findings, it appears as if trauma-focused treatment is most effective in 
reducing PTSD symptoms and has been shown to facilitate improvements in quality of 
life. Multiple valid and reliable assessments exist for this purpose, including the PCL-5 
and the CAPS, and the literature supports the concurrent use of either personality 
measures with validity indexes (e.g., MMPI-2-RF or PAI) or PTSD measures with 
embedded validity indexes (e.g., TSI).  
The assessment of quality of life in PTSD is complex, and, when possible, should 
be somewhat individualized for each client. This domain is closely linked to functional 
impairment, which can be assessed using biopsychosocial measures, global functioning 
measures, and with corroborating records. There are several potential approaches to 
assessing quality of life that have support in the literature, including assessing HRQoL or 
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administering individual measures of physical health, familial functioning, spirituality, 
resilience, and social support. It appears that the Q-LES-Q-SF measure has strong utility 
in assessing quality of life and can be helpful in focusing in quality of life assessment to 
essential ingredients. Additionally, for specific populations that experience unique 
challenges to quality of life (e.g., moral injury in military populations), it might be 
important to include relevant measures.  
The discussion in this literature review surrounding processes of well-being in 
PTSD is particularly important for the future of effective PTSD treatment. In particular, 
the findings from this literature review have shown that the syndromal model of PTSD, 
while appropriate in some ways, is incomplete, especially with respect to quality of life. 
While several processes (e.g., self-compassion, interpersonal connection, and 
psychological flexibility) appear to be crucial in improving quality of life in people with 
PTSD, it is unclear how these processes interact, and what methods of targeting them are 
most effective.  As such, it is important to examine these processes in clinical populations 
to help clinicians and researchers design and implement more efficient and expansive 
approaches to treatment. For reference, a list of acronyms discussed in this review is 
included in Table 1. 
Table 1 
Acronym Reference List 
PTSD Posttraumatic Stress Disorder 
FIT Feedback-Informed Treatment 
MBC Measurement-Based Care 
AAQ Acceptance and Action Questionnaire 
ROM Routine Outcome Monitoring 
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RCT Randomized Controlled Trial 
cPTSD Complex Posttraumatic Stress Disorder 
ESTs Empirically-Supported Treatments 
RCI Reliable Change Index 
REMs Racial Ethnic Minorities 
PE Prolonged Exposure 
CPT Cognitive Processing Therapy 
EMDR Eye-movement Desensitization and Reprocessing  






















Data were obtained from 537 adult patients who enrolled in an exposure-based 
PTSD partial hospitalization program (PHP), or intensive outpatient program (IOP) 
located in 8 Rogers Behavioral Health hospital satellite locations across the Midwest. 
Full demographic data is presented in Table 2. 75% of patients identified as White and 
83% identified as female. The average age in the dataset was approximately 36 (min = 
17, max = 79).  78% of our sample had at least one comorbid diagnosis, with Major 
Depressive Disorder (48%), Bipolar Disorder (17%), Generalized Anxiety Disorder 
(13%), and Alcohol Dependence (9%) being the most common comorbid conditions. 
Other comorbid diagnoses included Borderline Personality Disorder (6%), Panic Disorder 







N (%) or M (SD) 
N 537 
Female 446 (83%) 
Male 90 (17%) 
Race  
    White  400 (75%) 
     Black 41 (8%) 
     Pacific Islander 4 (1%) 
     Native American 8 (2%) 
     Asian 6 (1%) 
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     Multiple 1 (<1%) 
     Unknown 46 (9%) 
Ethnicity  
     Hispanic or Latino 27 (5%) 
     Not Hispanic or Latino 457 (85%) 
     Did Not Indicate 30 (5.6%) 
Age 36.10 (12.7); (Range: 17-79) 
Education  
     Some College 156 (29%) 
     Bachelor’s Degree 90 (17%) 
     High School Degree 50 (9%) 
     Other 142 (26%) 
     Associate’s Degree 32 (6%) 
     Master’s Degree 43 (8%) 
Marital Status  
     Married 137 (26%) 
     Divorced 62 (12%) 
     Single 261 (49%) 
     Separated 24 (5%) 
     Widowed 11 (2%) 
     Unknown 19 (3%) 
Sexual Orientation  
     Heterosexual 183 (80%) 
     Gay, Lesbian, or Bisexual 31 (14%) 
     Did Not Indicate 14 (6%) 
 
Trauma exposure was assessed using the Life Events Checklist (Weathers, Blake, 
et al., 2013), a self-report measure designed to allow participants to report lifetime 
exposure to a wide variety of traumatic events. 14% of participants did not indicate 
trauma exposure, so these data are not available for analysis. In this sample, total trauma 
exposure (M = 12.05, SD = 4.05) was approximately four times higher than rates found in 
the general population (cf. Benjet et al., 2016). The most common trauma exposures in 
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this sample were physical assault (77%), sexual assault (74%), and transportation 
accidents (72%), while the least common trauma exposures were causing serious injury 
to someone else (15%) and combat/warzone exposure (25%). In this sample, only 3% of 
participants indicated experiencing non-interpersonal traumas (e.g., transportation 
accident, natural disaster) without experiencing interpersonal trauma (e.g., sexual assault, 
physical assault, emotional abuse). As such, 97% of this sample experienced at least one 
interpersonal trauma. It should be noted that the LEC checklist does not measure total 
number of exposures, so it is likely that the vast majority of patients in the program 
experienced more than one instance of an indicated trauma (i.e., multiple assaults).  
Procedure 
 
The treatment in these evidence-based PTSD programs focuses concurrently on 
symptom reduction (via Prolonged Exposure for PTSD) and improving quality of life via 
the pursuit of meaning and values and engagement in contextual behavior treatment 
components (e.g., Acceptance and Commitment Therapy, Dialectical Behavioral 
Therapy, Compassion-Focused Therapy). Patients are screened by a psychologist and 
psychiatrist for diagnostic fit (i.e., patients have a primary diagnosis of PTSD) with the 
program. While PTSD must be the primary diagnosis for program admission, most 
patients present with at least one comorbid condition and have been in previous 
psychotherapy. Outside of having a primary diagnosis of PTSD, there are no strict 
exclusionary criteria for program participation, as the supervising psychologist and 
psychiatrist have final authority with respect to admission. However, active psychosis, 
significant cognitive impairment, and untreated substance use disorder generally result in 
admission to alternative treatment programs. All patients are given the Clinician-
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Administered PTSD Scale and the Mini-International Neuropsychiatric Interview (MINI) 
upon admission to further validate a primary diagnosis of PTSD, as well as the PTSD 
Checklist for DSM-5. Data from these assessments are not integrated into the aggregated 
master database available for research purposes, so they were not available for analysis. 
The program does not administer a dedicated measure of malingering, though in 
accordance with recommendations from Marx et al. (2012), supervising psychologists 
consider patient records, clinical interview results, and the malingering index of the PAI 
during the admissions process. Additionally, because the treatment program is structured, 
evidence-based, and requires consistent treatment engagement for continued enrollment, 
empirical studies have demonstrated that the obtained results have a low likelihood of 
bias from malingering (Marx et al., 2012). Unfortunately, at the time of this project, 
malingering data from the PAI was not fully integrated into the aggregated master 
database available for research purposes, so it was not available for analysis. 
Data were collected at three time points during patients’ first week in the 
program: at the step-down transition from partial hospitalization to intensive outpatient 
programming, and upon discharge. These timepoints are approximately 6 weeks apart, 
though there is variation due to differing individual patient needs. Additionally, weekly 
data measuring self-compassion, PTSD, and valued living is collected and was included 
in their respective growth curve analyses. Assessments are given in a uniform assessment 
battery administered on a HIPPA-compliant tablet. Patients’ received and signed 
informed consent papers prior to beginning the program indicating their consent to have 
their deidentified assessment data utilized for research purposes. As only consenting 
participants are included in databases available for analysis, no data were available to 
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contrast those who did not consent to engage in research with those who did. IRB 
approval was obtained before any analyses were conducted. 
Measures 
 
 Standard deviations and mean scores were calculated for all scales. Because 
Cronbach’s alpha is a measure of inter-item consistency and not reliability (Sijtsma, 
2009), Omega and maximal reliability (Peters, 2014) were also calculated to demonstrate 
scale reliability. 
PTSD Checklist (PCL-5)  
The PCL-5 (M = 54.17, SD = 12.70) is a 20-item self-report measure used to 
examine symptoms of PTSD severity by mapping on to PTSD criteria from the DSM-V 
(Weathers, Litz, et al., 2013). The measure is scored using a 5-point Likert scale (1 = Not 
at all, 4 = Extremely) where higher scores indicate greater symptom severity. The PCL-5 
has demonstrated strong convergent validity, discriminant validity, and adequate inter-
item correlation (Blevins, Weathers, Davis, Witte, & Domino, 2015). In our sample, 
inter-item correlation (α = .88) and reliability results for the PCL-5 (MR = .91, ω = .88) 
indicate a high proportion of shared variance that defines the underlying construct. 
Quality of Life Satisfaction Questionnaire – Short form (Q-LES-Q-SF) 
The Q-LES-Q-SF (M = 42.10, SD = 16.13) is a 16-item self-report measure 
examining quality of life and satisfaction (Endicott, Nee, Harrison, & Blumenthal, 1993). 
The measure is scored using a 5-point Likert scale (1 = very poor, 5 = very good) where 
higher scores suggest greater life satisfaction and quality of life. The Q-LES-Q-SF has 
demonstrated strong convergent validity, discriminant validity, and inter-item correlation 
(Riendeau et al., 2018). In our sample, inter-item correlation (α = .86) and reliability 
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results for the Q-LES-Q-SF (MR = .90, ω = .84) indicate a high proportion of shared 
variance that defines the underlying construct. 
Acceptance and Action Questionnaire (AAQ-II)  
The AAQ-II (M = 39.49, SD = 6.99) is a 7-item self-report measure of 
psychological inflexibility, or the attempt to alter the form, frequency, or situational 
sensitivity of negative thoughts and emotions (Bond et al., 2011). The measure is scored 
using a 7-point Likert scale (1 = never true, 7 = always true) where higher scores indicate 
elevated levels of psychological inflexibility. The AAQ-II has demonstrated convergent 
and discriminant validity, as well as adequate inter-item correlation (Gloster et al., 2011). 
In our sample, inter-item correlation (α = .89) and reliability results for the AAQ-II (MR 
= .90, ω = .89) indicate a high proportion of shared variance that defines the underlying 
construct. 
Awareness, Courage, and Responding (ACR)  
The “Courage” subscale (M = 26.34, SD = 6.34) of the ACR (ACR-C; Kanter et 
al., in press) is a 7-item measure of interpersonal courage, or willingness to be vulnerable 
in interpersonal interactions. The measure is scored using a 7-point Likert scale (1 = 
never true, 7 = always true) where higher scores indicate higher levels of interpersonal 
courage. Initial validation of the scale shows convergent validity, discriminant validity, 
and adequate inter-item correlation (Kanter et al., in press). In our sample, inter-item 
correlation (α = .84) and reliability results for the ACR-C (MR = .85, ω = .84) indicate a 




Valued Living Questionnaire (VLQ)  
The VLQ is a two-part self-report measure of Valued Living and Committed 
Action assessed across 10 domains (Wilson et al., 2010). The measure is scored using a 
10-point Likert scale (1 = not at all important, 10 = extremely important) where higher 
scores reflect greater valued living. The “Importance” scale asks the participant to rank 
10 life domains based on the importance of each value, while the “Consistency” scale 
asks the participant to report how consistent their actions have been with those same 
values. A composite score (M = 40.67, SD = 19.02) is calculated by taking the mean of 
the products of corresponding importance and consistency scores for each domain. This 
score indicates total valued living. 
Life Events Checklist (LEC-5) 
The LEC-5 is a 17-item self-report measure that allows participants to indicate 
trauma exposure history (Weathers, Blake, et al., 2013). In addition to indicating 
exposure to an unspecified stressful event or experience, 16 events that have been shown 
to potentially result in the development of PTSD events (e.g., sexual assault, combat or 
exposure to a war-zone) are rated using 6 nominal responses (Happened to me; 
Witnessed it; Learned about it; Part of my job; Not sure; Doesn’t apply). The LEC-5 is 
designed to be administered directly before the Clinician-Administered PTSD Scale for 
DSM-5 as the identifying mechanism for a person’s most prominent criterion A traumatic 
experience.  
Self-Compassion Scale (Short Form; SCS-SF)  
The SCS-SF (M = 26.33, SD = 7.38) is a 12-item self-report measure assessing 
self-compassion, i.e., showing self-kindness vs. self-judgment, being mindful vs. fused 
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with thoughts/emotion, and connecting with others vs. isolating (Neff, 2003; Raes et al., 
2011). Responses are given on a 5-point Likert-type scale (1 = almost never, 5 = almost 
always) where higher scores indicate elevated levels of self-compassion. Neff (2003) 
demonstrated that the SCS-SF has a “near-perfect correlation with the long form SCS” 
and has almost no loss in inter-item correlation for total scores. The SCS-SF has also 
demonstrated strong convergent and divergent validity (Castilho, Pinto-Gouveia, & 
Duarte, 2015). In our sample, inter-item correlation (α = .80) and reliability results for the 
SCS-SF (MR = .82, ω = .80) indicate a high proportion of shared variance that defines 
the underlying construct. 
Trauma-related Shame Inventory (TRSI) 
The TRSI (M = 41.84, SD = 18.30) is a 24-item self-report measure of internal 
and external trauma-related shame (Øktedalen, Hagtvet, Hoffart, Langkaas, & Smucker, 
2014). The measure is scored using a 4-point Likert scale (0 = never true, 3 = always 
true) where higher scores indicate elevated levels of trauma-related shame. The TRSI has 
demonstrated convergent and discriminant validity, as well as adequate inter-item 
correlation (DeCou, Mahoney, Kaplan, & Lynch, 2019). In our sample, inter-item 
correlation (α = .96) and reliability results for the PCL-5 (MR = .96, ω = .95) indicate a 
high proportion of shared variance that defines the underlying construct. 
Mini-International Neuropsychiatric Interview (MINI)  
The MINI is a structured diagnostic interview developed by Sheehan et al. (1998) 
for DSM-IV. The MINI has been shown to have strong evidence in support of its validity 




Data Analytic Strategy 
 
Change in Symptom Measures Over Time 
 
First, descriptive statistics were calculated to show symptom change over time 
(i.e., admission to discharge) on the variables under study. Reliable change indices (RCIs; 
Jacobson & Truax, 1991) were then calculated as function of mean admission scores, 
mean discharge scores, standard deviation at intake, and scale inter-item correlation, as 
measured by Cronbach’s alpha. Alphas are presented in the Measures section. The 
resulting RCI provided an absolute cutoff value that allowed us to determine if change in 
mean scores from admission to discharge is more than could be accounted for by 
measurement error. If the difference between the RCI and the change in mean scores was 
more than 1.96, which established a 95% confidence interval, we determined that we 
observed reliable change in the variables under study (Jacobson & Truax, 1991). 
Intent-to-treat Analysis 
Next, an intent-to-treat analysis compared participants who dropped out of 
treatment to those who completed treatment. Logistic regression was used to compare 
participants who dropped out of treatment against participants who completed treatment 
with respect to PTSD symptoms, quality of life, self-compassion, interpersonal courage, 
valued living, trauma-related shame, and psychological inflexibility, as well as 
demographic variables including race, gender, marital status, and education level.  
Discharge Model Confirmatory Factor Analysis 
As a precursor to a discharge latent regression model (discussed in the next 
section), a Confirmatory Factor Analysis (CFA) was conducted. This model contained a 
7-factor model for the PCL-5 (Grau, Garnier-Villarreal, & Wetterneck, 2019), a single 
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factor model for the Q-LES-Q-SF (Riendeau et al., 2018), a single factor model for the 
VLQ (Wilson et al., 2010), a 4-factor model for the TRSI (Øktedalen et al., 2014), a 2-
factor model for the SCS-SF (Seligowski et al., 2015), a single factor model for the 
AAQ-II (Bond et al., 2011), and a single factor model for the ACR-C (Kanter et al., in 
press). The 7-factor model for the PCL-5 comprised reexperiencing, avoidance, negative 
alterations (in cognition and mood), anhedonia, externalization, dysphoria, and anxious 
arousal factors, which were theoretically derived from previous research on the latent 
factor structure of the PCL-5 (e.g., Armour et al., 2015; Grau et al., 2019. The 4-factor 
model for the TRSI comprised internal condemnation, external condemnation, internal 
affective/behavioral, and external affective/behavioral factors, which is the original factor 
structure proposed by the scale authors (Øktedalen et al., 2014). The 2-factor model for 
the SCS-SF comprised positive self-compassion and negative self-compassion factors, 
which have been tested as an appropriate underlying factor structure for the scale 
(Seligowski et al., 2015). Factor reliability was assessed using Omega and maximal 
reliability (Peters, 2014). Overall and local model fit were estimated via absolute and 
relative fit indices as well as an examination of factor loadings. 
Discharge Latent Regression Model 
After estimating the CFA, a latent regression model was estimated with PTSD 
symptom severity (as measured by the 7-factor model for the PCL-5), quality of life (as 
measured by the single factor model for the Q-LES-Q-SF), valued living (as measured by 
the single factor model for the VLQ), and trauma-related shame discharge scores (as 
measured by the 4-factor model for the TRSI) set as outcomes and self-compassion (as 
measured by the 2-factor model for the SCS-SF), psychological inflexibility (as measured 
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by the single factor model for the AAQ-II), and interpersonal courage (as measured by 
the single factor model for the ACR-C) admission scores set as predictors. Race and 
gender were included as demographic covariates. 
Latent Growth Curve Models 
Next, latent growth curve analysis was used to assess if the rate of change in 
designated predictor variables predicted the rate of change in designated outcome 
variables (Grimm, Ram, & Estabrook, 2016). This was achieved using a structural 
equation modeling (SEM) approach, which allows for non-linear change models (Grimm 
et al., 2016). In this study, our unit of time was one week, which reflected programmatic 
administration of assessment batteries. For measures that were only given at stepdown to 
intensive outpatient programming and discharge from the program, the time interval is 
approximately 6-8 weeks. In addition to linear growth models that estimated a change 
matrix for the variables under study, SEM allowed for the estimation of multiple forms of 
growth models (i.e., quadratic, cubic, and spline models) that could be tested against one 
another to ascertain the best-fitting growth model for each individual longitudinal 
measure. Quadratic models adjust the change matrix by adding an additional growth 
factor that squares the linear values from the original linear model. Cubic models adjust 
the change matrix by adding another growth factor to a quadratic model that cubes the 
linear values from the original linear model. Finally, spline growth models adjust the 
change matrix at knot points that represent theoretical or data-driven turning points 
between distinct, time-based linear slopes (Grimm et al., 2016).  
The large number of latent regressions required for each dependent variable 
generated estimation problems for the full model, and as such, four separate models were 
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estimated to test each outcome variable separately (i.e., PTSD symptoms, valued living, 
quality of life, and trauma-related shame, respectively). All analyses were conducted in R 
3.5.0 (R Core Team, 2017) using the lavaan (Rosseel, 2012) package. Latent growth 
curve analysis can be conducted with three timepoints, so it is an appropriate method of 
analysis for our data (Little, 2013). While it would be possible to assess longitudinal 
variable change using other statistical methods (e.g., longitudinal panel modeling), latent 
growth curve analysis allowed us to assess intraindividual growth trends (Little, 2013), 
which is the focus of the research questions in this study. In clinical settings, this 
intraindividual focus can help identify core processes of change that can become 
treatment targets in efficient, transdiagnostic approaches (Hayes & Hofmann, 2018). 
Up to four separate growth curve models were estimated for each outcome 
variable. Linear, quadratic, cubic, and spline slopes were estimated and compared via 
Likelihood Ratio test (LRT, χ2) model comparison to retain the best-fitting model to the 
data (Little, 2013). The AAQ-II, ACR-C, TRSI, and Q-LES-Q-SF contained three 
timepoints for all included participants. The PCL-5, SCS-SF, and VLQ were 
administered weekly and, as such, contained a variable range of timepoints. The largest 
number of timepoints available for analysis was 25. Model fit statistics, including 
absolute and relative fit approximate indices, were calculated for all estimated latent 
growth curves. In line with recommendations from Beauducel and Wittmann (2005), fit 
indices were not interpreted as strict cutoffs for model interpretation. Instead, multiple fit 
indices, including Gamma Hat, were estimated to provide an overall view of the fit of 
each model to the data (Cheung & Rensvold, 2002). For the linear models, the majority 
of models displayed poor relative fit indices. This may be a result of model complexity or 
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elements of misspecification; however, the Gamma Hat index, which is a more robust fix 
index than the TLI and CFI (Fan & Sivo, 2007), is above .90 for all models. Based on 
recommendations from Marsh, Hau, and Wen (2004), a Gamma Hat value above .90 
suggests acceptable model fit. 
Latent Growth Curve Regressions 
From the estimated latent growth curve models, latent regressions were estimated  
to predict the intercept and slope of the PCL-5, Q-LES-Q-SF, VLQ, and TRSI, 
respectively. The intercepts and slopes of the AAQ-II, SCS-SF, and ACR-C were set as 
predictor variables in the latent regression models. In line with recommendations from 
Little (2013), pruned models, in which non-significant relationships are set to zero, were 
generated and compared to the initial models via LRT (χ2). Model pruning continued 
until a non-significant chi-square result was found. Final, pruned model results are 
reported. 
Missing Data 
Missing data were handled using Full Information Maximum Likelihood, which 
increases power and reduces the chance for bias in parameter estimation due to missing 
data (Enders, 2010). Growth curves were calculated using all available data with at least 
two primary (i.e., Admission, Stepdown, and Discharge) timepoints. If a participant did 
not have at least two timepoints, they were considered to have dropped out of treatment. 
Because this was a secondary data analysis, a power analysis was not conducted, and all 







 Results will be discussed first in terms of change in symptom measures over time, 
including a discussion of reliable change within the sample. This is followed by the 
results from the intent-to-treat analysis to assess predictors of dropout. Next, we will 
discuss the estimated discharge latent regression model and associated confirmatory 
factor analysis. Finally, full latent growth curve model analysis, as well as latent growth 
curve regression results, are presented.  
Change in Symptom Measures Over Time 
 
 Additional descriptive statistics, symptom change from admission to discharge 
and reliable change indices (RCIs), were computed to display the effectiveness of 
treatment. Clinical or non-clinical cutoff scores have not been determined for the Q-LES-
Q-SF, ACR-C, VLQ, or TRSI. Of the 343 patients who completed discharge PCL-5 
assessments, 185 (54%) reported scores below 33, which is the cutoff score 
recommended for inferring a PTSD diagnosis by Blevins, Weathers, Davis, Witte, and 
Domino (2015). For the SCS-SF, an average level of self-compassion in a non-clinical 
population is a total score of 36 (Neff, 2003). In our sample, out of the 352 patients who 
completed discharge SCS-SF assessments, 186 (53%) reported scores at or above the 
non-clinical population average levels of self-compassion. Of the 274 patients who 
completed discharge AAQ-II assessments, 146 (47%) reported scores below 28, which is 
the recommended cutoff score for problematic psychological inflexibility in non-clinical 
samples (Ong, Pierce, Woods, Twohig, & Levin, 2019). 54% of treatment completers 
indicated sub-clinical PTSD symptoms, 53% of treatment completers indicated levels of 
self-compassion at or above the estimated non-clinical average, and 47% of treatment 
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completers indicated levels of psychological inflexibility below recommended non-
clinical cutoff levels.  
Importantly, treatment effectiveness cannot be measured by comparing discharge 
scores to non-clinical cutoff scores, as it is possible to achieve significant clinical change 
while still maintaining elevated symptom profiles as compared to non-clinical 
populations (Jacobson & Truax, 1991). To address this issue, RCIs were calculated for 
each variable under study, as the RCI has been shown to measure whether an individual’s 
change is more than could be accounted for by measurement error (Jacobson & Truax, 
1991). Reliable change was observed for the PCL-5, Q-LES-Q-SF, SCS-SF, TRSI, and 
the AAQ-II. We did not observe reliable change in the ACR-C. An RCI was not 
calculated for the VLQ, as reliability estimates were not calculated (see the Measures 
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The intent-to-treat analysis compared participants who dropped out of treatment 
with participants who completed treatment based on demographic variables (i.e., age, 
race, educational status) and baseline scores on the predictor and outcome variables under 
study. Of the 537 participants with baseline data, 170 were categorized as having dropped 
out of treatment. A logistic regression was conducted to predict the change in probability 
of dropout based on PTSD symptoms, quality of life, self-compassion, interpersonal 
courage, valued living, trauma-related shame, and psychological inflexibility. 
Demographic variables, specifically race, gender, marital status, and education level were 
also entered into the model. No p values were below .05, and as such, we fail to reject the 
null hypothesis that dropout does not vary based on scores on the variables under study. 
This result means that it is unlikely that any of the symptom measures or demographic 
variables predict the likelihood of completing treatment. Full results for symptom 









SE p value CI 95% 
Odds 
Ratio 
Intercept 2.38 1.40 .09 -.33 – 5.15 10.86 
PTSD Symptoms -.00 .01 .78 -.03 - .02 .99 
Quality of Life .01 .01 .47 -.01, .02 1.01 
Self-Compassion -.03 .02 .14 -.07, .01 .97 
Interpersonal Courage -.02 .02 .37 -.06, .02 .98 
Valued Living .00 .01 .49 -.01, -.02 1.00 
Trauma-related Shame -.02 .01 .05 -.03, .00 .98 
Psychological Inflexibility -.01 .02 .78 -.06, .04 .99 
Gender (Female)      
Male .35 .33 .28 -.26, 1.02 1.42 
Race (Black)      
    White .69 .42 .10 -.15, 1.52 1.99 
    Unknown .96 .55 .08 -.11, 2.07 2.62 
    Other .86 .74 .25 -.54, 2.40 2.36 
Education (Some College)      
    Bachelor’s Degree -.01 .36 .97 -.72, .71 .99 
    High School Degree -.29 .44 .50 -1.14, .59 .75 
    Other -.50 .30 .09 -1.09, .08 .61 
    Associate’s Degree .39 .61 .52 -.72, 1.71 1.48 
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    Master’s Degree -.64 .47 .17 -1.56, .29 .52 
Marital Status (Single)      
    Married -.15 .43 .74 -.49, .63 1.07 
    Divorced .53 .41 .18 -.23, 1.37 1.70 
    Separated .17 .56 .76 -.88, 1.37  1.19 
    Widowed 1.50 1.13 .18 -.35, 4.49 4.46 
    Unknown -.26 .62 .67 -1.45, 1.02 .77 
 
Discharge Model Confirmatory Factor Analysis 
 
 A CFA was estimated for the discharge latent regression model. This model 
contained a 7-factor model for the PCL-5 (Grau, Garnier-Villarreal, & Wetterneck, 
2019), a single factor model for the Q-LES-Q-SF (Riendeau et al., 2018), a single factor 
model for the VLQ (Wilson et al., 2010), a 4-factor model for the TRSI (Øktedalen et al., 
2014), a 2-factor model for the SCS-SF (Seligowski et al., 2015), a single factor model 
for the AAQ-II (Bond et al., 2011), and a single factor model for the ACR-C (Kanter et 
al., in press). The 7-factor model for the PCL-5 comprised reexperiencing, avoidance, 
negative alterations (in cognition and mood), anhedonia, externalization, dysphoria, and 
anxious arousal factors.  
Based on a test of modification indices that was informed by scale theory, five 
residual correlations were included in the model. For the residual correlations, two were 
found between TRSI external condemnation items, two were found between 
psychological inflexibility items and one was found between valued living items. For the 
AAQ-II, the first residual correlation was between “My painful experiences and 
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memories make it difficult for me to live a life that I would value” and “My painful 
memories prevent me from having a fulfilling life” (r = .38 p < .001). The second 
residual correlation was between “I’m afraid of my feelings” and “I worry about not 
being able to control my worries and feelings” (r = .88, p < .001). For the TRSI, the first 
residual correlation was between “If others knew what happened to me, they would not 
like me” and “If others knew what happened to me, they would find me unacceptable” (r 
= .42, p < .001). The second residual correlation was between “I am ashamed of the way I 
behaved during my traumatic experience” and “If others knew how I behaved during my 
traumatic experience, they would be ashamed of me” (r = .38 p < .001). For the VLQ, the 
residual correlation was between “Friends / social life” and “Recreation / fun” (r = .48, p 
< .001). 
Model fit for the discharge latent regression model was acceptable (X2 (2941) = 
5323.06, RMSEA = .04 CI[.04, .04], CFI = .89, TLI = .88, Gamma Hat = .90). For the 
PCL-5, the factor loadings for the 7-factor solution were strong, overall. Standardized 
factor loadings ranged from .76 to .90 for the Re-experiencing factor, .86 to .92 for the 
Avoidance factor, .82 to .90 for the Negative Alterations factor, .87 to .89 for the 
Anhedonia factor, .57 to .83 for the Externalizing Behaviors factor, .65 to .77 for the 
Dysphoric Arousal factor, and .83 to .93 for the Anxious Arousal factor. R2 values have a 
mean of .70, and a range of .42 to .86, which indicates the shared item variance for the 
respective factor is high. Full reliability results for the CFA are included in Table 5.  
 
Table 5 
CFA Reliability Estimates 
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 Omega AVE MR 
PCL-5 Model    
     Re-Experiencing .90 .73 .91 
     Avoidance .88 .79 .88 
     Negative Alterations .89 .73 .89 
     Anhedonia .90 .78 .91 
     Externalizing Behaviors .70 .56 .70 
     Dysphoric Arousal .67 .51 .67 
     Anxious Arousal .86 .77 .86 
     Factor Model .96 .71 .97 
Q-LES-Q-SF    
     Factor Model .90 .53 .90 
VLQ    
     Factor Model .85 .47 86 
TRSI    
     Internal Condemnation .89 .64 .91 
     Internal Affective-   
     behavioral 
.89 .64 .90 
     External Condemnation  .91 .66 .92 
     External Affective- 
     behavioral 
.92 .65 .92 
     Factor Model .95 .64 .96 
SCS-SF    
     Positive  .76 .36 .77 
     Negative .75 .39 .75 
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     Factor Model    
AAQ-II         
     Factor Model .88 .56 .88 
ACR-C    
     Factor Model .84 .52 .84 
Note. MR = Maximal Reliability. AVE = Average Variance Extracted. 
 
Based on an upper reliability threshold (represented by maximal reliability) and a 
lower reliability threshold (represented by Omega), for the PCL-5, the “Dysphoric 
Arousal” factor appears to be the least precise construct measure with “Anhedonia” and 
“Re-experiencing” being the most precise construct measures. For the TRSI, the "Internal 
Affective-behavioral” factor appears to be the least precise construct measure with 
“External Affective-behavioral” being the most precise construct measure. It should be 
noted that these differences are extremely small and that all reliability measures for the 
TRSI are largely consistent. For the SCS-SF, the “Negative” factor appears to be a 
slightly less precise construct measure than the “Positive” factor. Overall, all reliability 
estimates are strong. 
For the Q-LES-Q-SF single factor solution, standardized factor loadings ranged 
from .59 to .89. R2 values have a mean of .55, and a range of .35 to .80, which indicates 
the shared item variance for the respective factor is high. 
For the VLQ single factor solution, standardized factor loadings ranged from .60 
to .73. R2 values have a mean of .47, and a range of .37 to .53, which indicates the shared 
item variance for the respective factor is high. 
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For the TRSI, the factor loadings for the 4-factor solution were strong, overall. 
Standardized factor loadings ranged from .72 to .86 for the Internal Condemnation factor, 
.68 to .88 for the Internal Affective-behavioral factor, .63 to .89 for the External 
Condemnation factor, and .74 to .89 for the External Affective-behavioral factor. R2 
values have a mean of .62, and a range of .40 to .80, which indicates the shared item 
variance for the respective factors is high. 
For the SCS-SF, the factor loadings for the 2-factor solution were strong, overall. 
Standardized factor loadings ranged from .60 to .67 for the Positive Self-compassion 
factor to .64 to .71 for the Internal Negative Self-compassion factor. R2 values have a 
mean of .44, and a range of .36 to .51, which indicates the shared item variance for the 
respective factor is high. 
For the AAQ-II single factor solution, standardized factor loadings ranged from 
.63 to .84. R2 values have a mean of .56, and a range of .39 to .71, which indicates the 
shared item variance for the respective factor is high. 
For the ARC-C single factor solution, standardized factor loadings ranged from 
.66 to .79. R2 values have a mean of .52, and a range of .43 to .63, which indicates the 
shared item variance for the respective factor is high. 
Discharge Latent Regression Model 
 
PTSD symptom severity (i.e., PCL-5), quality of life (i.e., Q-LES-Q-SF), valued 
living (i.e., VLQ), and trauma-related shame (i.e., TRSI) discharge scores set as 
outcomes and self-compassion (i.e., SCS-SF), psychological inflexibility (i.e., AAQ-II), 
and interpersonal courage (i.e., ACR-C) admission scores set as predictors. 
Discharge PTSD Symptoms  
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Discharge PTSD Reexperiencing Factor. Admission self-compassion, 
psychological inflexibility, and interpersonal courage explained 8% of the variance in the 
discharge PTSD reexperiencing factor (R2 = .08). At p < .001, only psychological 
inflexibility (β = .38, SE = .11) was significantly related to the PTSD reexperiencing 
factor. As admission psychological inflexibility scores increased by one standard 
deviation, discharge PTSD reexperiencing symptoms increased by .37 standard 
deviations. Admission positive self-compassion (β = .06, SE = .16, p = .577), negative 
self-compassion (β = .17, SE = .12, p = .152), and interpersonal courage (β = .10, SE = 
.09, p = .239) were not related to discharge PTSD reexperiencing symptoms. Gender (β = 
.07, SE = .15, p = .665) and race (β = -.04, SE = .02, p = .050) were not significant 
predictors. 
Discharge PTSD Avoidance Factor. Admission self-compassion, psychological 
inflexibility, and interpersonal courage explained 8% of the variance in the discharge 
PTSD avoidance factor (R2 = .06). Only admission psychological inflexibility (β = .32, 
SE = .10, p = .002) was significantly related to discharge PTSD avoidance symptoms. As 
psychological inflexibility scores increased by one standard deviation, PTSD avoidance 
symptoms increased by .31 standard deviations. Admission positive self-compassion (β = 
.07, SE = .12, p = .564), negative self-compassion (β = .15, SE = .12, p = .206), and 
interpersonal courage (β = .03, SE = .08, p = .741) were not related to discharge PTSD 
avoidance symptoms. Gender (β = .14, SE = .16, p = .378) and race (β = -.01, SE = .02, p 
= .52) were not significant predictors. 
Discharge PTSD Negative Alterations Factor. Admission self-compassion, 
psychological inflexibility, and interpersonal courage explained 7% of the variance in the 
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discharge PTSD negative alterations (in cognitions and mood) factor (R2 = .07). Only 
admission psychological inflexibility (β = .28, SE = .10, p = .006) was significantly 
related to discharge PTSD negative alterations (in cognition and mood). As psychological 
inflexibility scores increased by one standard deviation, PTSD negative alterations (in 
cognitions and mood) increased by .27 standard deviations. Admission positive self-
compassion (β = .02, SE = .11, p = .849), negative self-compassion (β = -.01, SE = .11, p 
= .944), and interpersonal courage (β = .05, SE = .08, p = .540) were not related to 
discharge PTSD negative alterations (in cognitions and mood). Gender (β = -.04, SE = 
.15, p = .812) and race (β = -.01, SE = .02, p = .813) were not significant predictors. 
Discharge PTSD Anhedonia Factor. Admission self-compassion, psychological 
inflexibility, and interpersonal courage explained 8% of the variance in the discharge 
PTSD anhedonia factor (R2 = .08). Only admission psychological inflexibility (β = .36, 
SE = .10, p < .001) was significantly related to discharge PTSD anhedonia. As admission 
psychological inflexibility scores increased by one standard deviation, discharge PTSD 
anhedonia increased by .35 standard deviations. Admission positive self-compassion (β = 
-.01, SE = .11, p = .943), negative self-compassion (β = .11, SE = .12, p = .321), and 
interpersonal courage (β = .07, SE = .08, p = .432) were not related to discharge PTSD 
anhedonia. Gender (β = .29, SE = .16, p = .057) and race (β = -.02, SE = .02, p = .532) 
were not significant predictors. 
Discharge PTSD Externalization Factor. Admission self-compassion, 
psychological inflexibility, and interpersonal courage explained 3% of the variance in the 
discharge PTSD externalization factor (R2 = .03). Admission psychological inflexibility 
(β = .15, SE = .13, p = .195), positive self-compassion (β = 10, SE = .13, p = .965), 
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negative self-compassion (β = -.01, SE = .13, p = .885), and interpersonal courage (β = 
.11, SE = .09, p = .235) were not related to discharge PTSD externalization. Gender (β = 
.26, SE = .17, p = .130) and race (β = -.02, SE = .02, p = .532) were not significant 
predictors. 
Discharge PTSD Dysphoria Factor. Admission self-compassion, psychological 
inflexibility, and interpersonal courage explained 7% of the variance in the discharge 
PTSD dysphoria factor (R2 = .07). Only admission psychological inflexibility (β = .30, SE 
= .12, p = .012) was significantly related to discharge PTSD dysphoria. As admission 
psychological inflexibility scores increased by one standard deviation, discharge PTSD 
dysphoria increased by .09 standard deviations. Admission positive self-compassion (β = 
.09, SE = .13, p = .484), negative self-compassion (β = -.01, SE = .13, p = .963), and 
interpersonal courage (β = -.02, SE = .10, p = .873) were not related to discharge PTSD 
dysphoria. Gender (β = -.16, SE = .18, p = .364) and race (β = -.02, SE = .03, p = .471) 
were not significant predictors. 
Discharge PTSD Anxious Arousal Factor. Admission self-compassion, 
psychological inflexibility, and interpersonal courage explained 9% of the variance in the 
discharge PTSD anxious arousal factor (R2 = .09). At p < .001, only psychological 
inflexibility (β = .39, SE = .11) was significantly related to the discharge PTSD anxious 
arousal factor. As admission psychological inflexibility scores increased by one standard 
deviation, discharge PTSD anxious arousal increased by .37 standard deviations. 
Admission positive self-compassion (β = .11, SE = .12, p = .345), negative self-
compassion (β = .07, SE = .12, p = .534), and interpersonal courage (β = .12, SE = .09, p 
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= .181) were not related to discharge PTSD anxious arousal. Gender (β = .27, SE = .16, p 
= .091) and race (β = -.00, SE = .02, p = .919) were not significant predictors. 
Discharge Quality of Life  
Admission self-compassion, psychological inflexibility, and interpersonal courage 
explained 4% of the variance in discharge quality of life (R2 = .04). Admission positive 
self-compassion (β = .03, SE = .11, p = .793), negative self-compassion (β = .05, SE = 
.11, p = .649), psychological inflexibility β = -.17, SE = .10, p = .085), and interpersonal 
courage (β = -.08, SE = .08, p = .354) were not significant predictors of discharge quality 
of life. Gender (β = .06, SE = .17, p = .961) and race (β = -.03, SE = .02, p = .287) were 
not significant predictors. 
Discharge Trauma-related Shame 
Discharge Trauma-related Shame Internal Condemnation Factor. Admission 
self-compassion, psychological inflexibility, and interpersonal courage explained 7% of 
the variance in the discharge TRSI internal condemnation factor (R2 = .07). Admission 
positive self-compassion (β = .05, SE = .11, p = .694), negative self-compassion (β = -.15, 
SE = .11, p = .194), psychological inflexibility (β = .18, SE = .10, p = .069), and 
interpersonal courage (β = .02, SE = .08, p = .796) were not significant predictors of 
discharge TRSI internal condemnation. Gender (β = .01, SE = .15, p = .975) and race (β = 
-.04, SE = .02, p = .059) were not significant predictors. 
Discharge Trauma-related Shame Internal Affective-behavioral Factor. 
Admission self-compassion, psychological inflexibility, and interpersonal courage 
explained 6% of the variance in the discharge TRSI internal affective-behavioral factor 
(R2 = .06). Admission positive self-compassion (β = .15, SE = .11, p = .201), negative 
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self-compassion (β = -.17, SE = .12, p = .144), psychological inflexibility (β = .19, SE = 
.10, p = .060), and interpersonal courage (β = -.01, SE = .08, p = .923) were not 
significant predictors of discharge TRSI affective-behavioral shame. Gender (β = -.01, SE 
= .15, p = .975) and race (β = -.03, SE = .02, p = .206) were not significant predictors. 
Discharge Trauma-related Shame External Condemnation Factor. Admission 
self-compassion, psychological inflexibility, and interpersonal courage explained 3% of 
the variance in the discharge TRSI external condemnation factor (R2 = .03). Admission 
positive self-compassion (β = .05, SE = .11, p = .659), negative self-compassion (β = -.06, 
SE = .11, p = .606), psychological inflexibility (β = .17, SE = .10, p = .103), and 
interpersonal courage (β = .02, SE = .08, p = .853) were not significant predictors of 
discharge TRSI external condemnation. Gender (β = .14, SE = .15, p = .346) and race (β 
= -.02, SE = .02, p = .429) were not significant predictors. 
Discharge Trauma-related Shame External Affective-behavioral Factor.  
Admission self-compassion, psychological inflexibility, and interpersonal courage  
explained 4% of the variance in the discharge TRSI external affective-behavioral factor 
(R2 = .04). Admission positive self-compassion (β = .04, SE = .11, p = .718), negative 
self-compassion (β = -.13, SE = .11, p = .256), psychological inflexibility β = .12, SE = 
.10, p = .242), and interpersonal courage (β = .00, SE = .08, p = .970) were not significant 
predictors of discharge TRSI external affective-behavioral shame. Gender (β = .10, SE = 
.15, p = .531) and race (β = -.01, SE = .02, p = .744) were not significant predictors. 
Discharge Valued Living 
Admission self-compassion, psychological inflexibility, and interpersonal courage 
explained 14% of the variance in discharge valued living (R2 = .14). Only admission 
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interpersonal courage (β = .19, SE = .09, p = .032) was significantly related to the 
discharge valued living. As admission interpersonal courage scores increased by one 
standard deviation, discharge PTSD anxious arousal increased by .18 standard deviations. 
Admission positive self-compassion (β = .15, SE = .13, p = .224), negative self-
compassion (β = .07, SE = .13, p = .578), and psychological inflexibility (β = -.13, SE = 
.10, p = .228) were not related to discharge valued living. Gender (β = -.01, SE = .17, p = 
.961) and race (β = -.03, SE = .02, p = .287) were not significant predictors. 
Latent Growth Curve Models 
 
 Latent growth curve models were estimated for PTSD symptom severity, self-
compassion, valued living, psychological inflexibility, interpersonal courage, quality of 









PCL-5 Means Over Time 
 
Note. Red lines indicate knot points that separate linear curves within the spline model. 
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Figure 2 
SCS-SF Means Over Time 
 
Note. Red lines indicate knot points that separate linear curves within the spline model. 
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Figure 3 
VLQ Means Over Time 
 
Note. Red lines indicate knot points that separate linear curves within the spline model. 
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Figure 4 
ACR-C Means Over Time 
 
Note. 6 weeks represents the average time in partial hospitalization treatment. 6-12 weeks represents the average time spent in 
intensive outpatient treatment. These are not exact timeframes and vary between participants. 
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Figure 5 
AAQ-II Means Over Time 
 
 
Note. 6 weeks represents the average time in partial hospitalization treatment. 6-12 weeks represents the average time spent in 
intensive outpatient treatment. These are not exact timeframes and vary between participants. 
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Figure 6 
Q-LES-Q-SF Means Over Time 
 
Note. 6 weeks represents the average time in partial hospitalization treatment. 6-12 weeks represents the average time spent in 
intensive outpatient treatment. These are not exact timeframes and vary between participants. 
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Figure 7 
TRSI Means Over Time 
 
Note. 6 weeks represents the average time in partial hospitalization treatment. 6-12 weeks represents the average time spent in 
intensive outpatient treatment. These are not exact timeframes and vary between participants.
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PCL-5 Growth Model  
First, linear, quadratic, and cubic slopes were estimated for the PCL-5. Only the  
linear slope model converged, preventing model comparison via LRT. Upon examination 
of plotted values, a three-piece spline model was estimated. Spline models are especially 
useful when each knot point is associated with a discernable reason for the change in 
slope (Grimm et al., 2016). For the PCL-5, knot points were discovered after week 6 of 
treatment and after week 16 of treatment. Week 6 is especially meaningful, as it 
represents a full course of partial hospitalization programming and the stepdown to 
intensive outpatient programming. Week 16 is approximately 4 weeks after the intended 
discharge date from intensive outpatient, though given the variable length of treatment 
for participants, this knot point represents data from patients who required additional 
treatment time to complete the program. This spline model was compared to the linear 
model via LRT (Δ X2 = 659.33, Δ df = 9, p < .001), after which the spline model was 
retained as the best-fitting model to the data. Model fit for the PCL-5 spline model was 
also acceptable (X2 (337) = 882.28, RMSEA = .05 CI[.05, .06], CFI = .86, TLI = .86, 
Gamma Hat = .93). The estimated PCL-5 intercept (at admission) was 54.39 (SE = .56, p 
< .001). The first two linear slopes were significant at alpha level p <. 001. However, the 
third linear slope was not significant (p = .068). For the first linear slope, on average, 
PCL-5 scores decreased 2.01 units (SE = .15, p <. 001) per week. For the second linear 
slope, on average, PCL-5 scores decreased 1.34 units (SE = .20, p <. 001) per week. 




SCS-SF Growth Model  
First, linear, quadratic, and cubic slopes were estimated for the SCS-SF. Only the  
linear slope model and the quadratic slope model converged. These models were 
compared using LRT (Δ X2 = 462.32, Δ df = 4, p < .001), after which the quadratic model 
was retained. However, upon examination of plotted values, a three-piece spline model 
appeared to be a better fit to the data and was therefore estimated. Mirroring results for 
the PCL-5, knot points were discovered after week 6 of treatment and after week 16 of 
treatment. This spline model was compared to the quadratic model via LRT (Δ X2 = 
140.21, Δ df = 5, p < .001), after which the spline model was retained as the best-fitting 
model to the data. Model fit for the SCS-SF spline model was acceptable (X2 (337) = 
944.12, RMSEA = .05 CI[.05, .06], CFI = .86, TLI= .87, Gamma Hat = .92). The 
estimated SCS-SF intercept (at admission) was 26.13 (SE = .35, p < .001). The first two 
linear slopes were significant at alpha level p < .001. However, the third linear slope was 
not significant (p = .580). For the first linear slope, on average, SCS-SF scores increased 
.73 units (SE = .08) per week. For the second linear slope, on average, SCS-SF scores 
increased .46 units (SE = .10) per week. Finally, for the third linear slope, SCS-SF scores 
increased .06 units (SE = .10) per week. 
VLQ Growth Model  
First, linear, quadratic, and cubic slopes were estimated for the VLQ. Only the  
linear slope model and the quadratic slope model converged. These models were 
compared using LRT (Δ X2 = 215.97, Δ df = 4, p < .001), after which the quadratic model 
was retained. However, upon examination of plotted values, a three-piece spline model 
appeared to be a better fit to the data and was therefore estimated. Mirroring results for 
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the VLQ and SCS-SF, knot points were discovered after Week 6 of treatment and after 
Week 16 of treatment. This spline model was compared to the quadratic model via LRT 
(Δ X2 = 462.32, Δ df = 4, p < .001), after which the spline model was retained as the best-
fitting model to the data. model fit for the VLQ spline model was also acceptable (X2 
(337) = 942.56, RMSEA = .06 CI[.06, .07], CFI = .86, TLI = .87, Gamma Hat = .91). The 
estimated VLQ intercept (at admission) was 38.62 (SE = .17, p < .001). The first two 
linear slopes were significant at alpha level p <. 05. However, the third linear slope was 
not significant (p = .589). For the first linear slope, on average, VLQ scores increased .85 
units (SE = .17) per week. For the second linear slope, on average, VLQ scores increased 
.53 units (SE = .15) per week. Finally, for the third linear slope, VLQ scores increased .09 
units (SE = .16) per week. 
AAQ-II Growth Model   
Linear, quadratic, and cubic slopes were estimated for the AAQ-II. Only the  
linear model converged, which prevented model comparison via LRT. Based on 
recommendations from Marsh, Hau, and Wen (2004), model fit for the AAQ-II linear 
model was acceptable (X2 (475) = 35.88, RMSEA = .27 CI[.20, .35], CFI = .71, TLI = 
.13, Gamma Hat = .95). Scores decreased consistently from admission to discharge. The 
estimated AAQ-II intercept (at admission) was 25.73 (SE = 5.96, p < .001). The linear 
slope was significant at alpha level p < .001 On average, AAQ-II scores decreased .36 
units (SE = .06) per six weeks. 
ACR-C Growth Model  
Linear, quadratic, and cubic slopes were estimated for the ACR-C. Only the linear  
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model converged, which prevented model comparison via LRT. Based on 
recommendations from Marsh, Hau, and Wen (2004), model fit for the ACR-C linear 
model was acceptable (X2 (484) = 2.97, RMSEA = .06 CI[.00, .15], CFI = .99, TLI = .98, 
Gamma Hat = .99). Scores increased gradually from admission to discharge. The 
estimated ACR-C intercept (at admission) was 21.99 (SE = 2.94, p < .001). The linear 
slope was not significant (p = .918). On average, ACR-C scores increased .002 units (SE 
= .02, p < .001) per six weeks. 
TRSI Growth Model  
Linear, quadratic, and cubic slopes were estimated for the TRSI. Only the linear  
model converged, which prevented model comparison via LRT. Based on 
recommendations from Marsh, Hau, and Wen (2004), model fit for the TRSI linear model 
was acceptable (X2 (515) = 23.21, RMSEA = .21 CI[.14, .29], CFI = .87, TLI = .62, 
Gamma Hat = .97). Scores decreased gradually from admission to discharge. The 
estimated TRSI intercept (at admission) was 41.01 (SE = .85, p < .001). The linear slope 
was significant at alpha level p <. 001. On average, TRSI scores decreased .77 units (SE 
= .04, p < .001) per six weeks.  
Q-LES-Q-SF Growth Model  
Linear, quadratic, and cubic slopes were estimated for the AAQ-II. Only the  
linear model converged, which prevented model comparison via LRT. Based on 
recommendations from Marsh, Hau, and Wen (2004), model fit for the Q-LES-Q-SF 
linear model was acceptable (X2 (512) = 23.68, RMSEA = .21 CI[.14, .29], CFI = .92, 
TLI = .75, Gamma Hat = .97). Scores increased gradually from admission to discharge. 
The estimated Q-LES-Q-SF intercept (at admission) was 42.62 (SE = .73, p < .001). The 
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linear slope was significant at alpha level p <. 001. On average, Q-LES-Q-SF scores 
increased .62 (SE = .18) units per six weeks. 
Latent Growth Curve Regressions 
 
            After calculating intercepts and slopes for each variable under study, latent 
regressions were estimated to predict the intercept and slope of the PCL-5, Q-LES-Q-SF, 
VLQ, and TRSI, respectively. Per recommendations from Little (2013), because the 
tested models are theory-based and not exploratory, non-significant relationships were 
pruned, or set to zero, after which the pruned models were compared to previous models 
via LRT (χ2). Model pruning continued until a non-significant chi-square result was 
found. Final, pruned model results are reported. 
PCL-5 Latent Growth Curve Regression Model 
For the first model, the PCL-5 intercept and the three PCL-5 linear slopes set as 
outcome variables. The SCS-SF intercept, the three SCS-SF linear slopes, the AAQ-II 
intercept, the AAQ linear slope, the ACR-C intercept, and the ARC-C linear slope were 
set as predictor variables.  
PCL-5 Final Latent Growth Curve Regression Model. A pruned PCL-5 model 
was compared to the original model via LRT (Δ X2 = 47.12, Δ df = 14, p < .001), after 
which the pruned model was retained. After model pruning, only the AAQ-II intercept (β 
= 1.98, SE = .18, p < .001) and the ACR-C intercept (β = .36, SE = .15, p = .018) were 
significant predictors of the PCL-5 intercept. Thus, we reject the null hypothesis of these 
intercept relationships being equal to zero. As the AAQ-II intercept increased by 1 
standard deviation, the PCL-5 intercept increased by .97 deviations. As the ACR-C 
intercept increased by 1 standard deviation, the PCL-5 intercept increased by .16 standard 
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deviations. For the first PCL-5 linear slope, after model pruning, only the first SCS-SF 
linear slope (β = -1.58, SE = .13, p < .001) was a significant predictor. Thus, we reject the 
null hypothesis of this regression slope being equal to zero. As the first SCS-SF linear 
slope increased by 1 standard deviation, the first PCL-5 linear slope decreased by .91 
standard deviations. For the second PCL-5 linear slope, after model pruning, only the 
second SCS-SF linear slope (β = -1.60, SE = .21, p < .001) was a significant predictor. 
Thus, we reject the null hypothesis of this regression slope being equal to zero. As the 
second SCS-SF linear slope increased by 1 standard deviation, the second PCL-5 linear 
slope decreased by .87 standard deviations. For the third PCL-5 linear slope, after model 
pruning, only the third SCS-SF linear slope (β = -1.81, SE = .61, p = .003) was a 
significant predictor. Thus, we reject the null hypothesis of this regression slope being 
equal to zero. As the third SCS-SF linear slope increased by 1 standard deviation, the 
third PCL-5 linear slope decreased by 1.02 standard deviations.  
VLQ Latent Growth Curve Regression Model  
For the second model, the VLQ intercept and the three VLQ linear slopes set as 
outcome variables. The SCS-SF intercept, the three SCS-SF linear slopes, the AAQ-II 
intercept, the AAQ linear slope, the ACR-C intercept, and the ARC-C linear slope were 
set as predictor variables.  
VLQ Final Latent Growth Curve Regression Model. A pruned VLQ model 
was compared to the original model via LRT (Δ X2 = 66.58, Δ df = 20, p < .001), after 
which the pruned model was retained. After model pruning, only the first SCS-SF linear 
slope (β = 4.81, SE = 1.85, p = .009) was a significant predictor of the VLQ intercept. 
Thus, we reject the null hypothesis of these intercept relationships being equal to zero. As 
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the first SCS-SF linear slope increased by 1 standard deviation, the VLQ intercept 
increased by .47 standard deviations.  
For the first VLQ linear slope, after model pruning, the first SCS-SF slope (β = 
.62, SE = .15, p < .001), the AAQ-II intercept (β = -.07, SE = .03, p = .026), and the 
AAQ-II linear slope (β = -1.49, SE = .60, p = .013) were significant predictors. Thus, we 
reject the null hypothesis of these regression slopes being equal to zero. As the first SCS-
SF linear slope increased by 1 standard deviation, the first VLQ linear slope increased by 
.41 units. As the AAQ-II intercept increased by 1 standard deviation, the first VLQ linear 
slope decreased by .18 standard deviations. As the AAQ-II linear slope increased by 1 
standard deviation, the first VLQ linear slope decreased by .29 standard deviations. For 
the second VLQ linear slope, after model pruning, only the second SCS-SF linear slope 
(β = .96, SE = .11, p < .001) was a significant predictor. Thus, we reject the null 
hypothesis of this regression slope being equal to zero. As the second SCS-SF linear 
slope increased by 1 standard deviation, the second VLQ linear slope decreased by .78 
standard deviations. For the third VLQ linear slope, after model pruning, only the third 
SCS-SF linear slope (β = .96, SE = .12, p < .001) was a significant predictor. Thus, we 
reject the null hypothesis of this regression slope being equal to zero. As the third SCS-
SF linear slope increased by 1 standard deviation, the third VLQ linear slope increased by 
.79 standard deviations.  
Q-LES-Q-SF Latent Growth Curve Regression Model  
For the third model, the Q-LES-Q-SF intercept and the Q-LES-Q-SF linear slope 
were set as outcome variables. The SCS-SF intercept, the three SCS-SF linear slopes, the 
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AAQ-II intercept, the AAQ linear slope, the ACR-C intercept, and the ARC-C linear 
slope were set as predictor variables.  
Q-LES-Q-SF Final Latent Growth Curve Regression Model. A pruned PCL-5 
model was compared to the original model via LRT (Δ X2 = 40.66, Δ df = 10, p < .001), 
after which the pruned model was retained. After model pruning, only the SCS-SF third 
linear slope (β = 2.08, SE = 1.04 p = .045) and the AAQ-II intercept (β = -2.08, SE = .23, 
p < .001) were significant predictors of the Q-LES-Q-SF intercept. Thus, we reject the 
null hypothesis of these intercept relationships being equal to zero. As the third SCS-SF 
linear slope increased by 1 standard deviation, the Q-LES-Q-SF intercept increased by 
.24 standard deviations. As the AAQ-II intercept increased by 1 standard deviation, the 
Q-LES-Q-SF intercept decreased by .93 standard deviations. 
For the Q-LES-Q-SF linear slope, after model pruning, only the AAQ-II linear 
slope (β = -1.00, SE = .20, p < .001) was a significant predictor. Thus, we reject the null 
hypothesis of this regression slope being equal to zero. As the AAQ-II linear slope 
increased by 1 standard deviation, the Q-LES-Q-SF linear slope decreased by .62 
standard deviations.  
TRSI Latent Growth Curve Regression Model  
For the fourth model, the TRSI intercept and the TRSI linear slope were set as 
outcome variables. The SCS-SF intercept, the three SCS-SF linear slopes, the AAQ-II 
intercept, the AAQ linear slope, the ACR-C intercept, and the ARC-C linear slope were 
set as predictor variables.  
TRSI Final Latent Growth Curve Regression Model. A pruned PCL-5 model 
was compared to the original model via LRT (Δ X2 = 14.67, Δ df = 10, p = .145), after 
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which the original model was retained. In the original model, the second SCS-SF linear 
slope (β = -8.49, SE = 4.07, p = .037), the third SCS-SF linear slope (β = -9.39, SE = 
4.15, p = .024), and the AAQ-II intercept (β = 2.10, SE = .20, p < .001) were significant 
predictors of the TRSI intercept. Thus, we reject the null hypothesis of these intercept 
relationships being equal to zero. As the second SCS-SF linear slope increased by 1 
standard deviation, the TRSI intercept decreased by .84 standard deviations. As the third 
SCS-SF linear slope increased by 1 standard deviation, the TRSI intercept decreased by 
.91 standard deviations. As the AAQ-II intercept increased by 1 standard deviation, the 
TRSI intercept increased by .74 standard deviations.  
For the TRSI linear slope, only the SCS-SF intercept (β = .01, SE = .01, p = .010), 
AAQ-II linear slope (β = .88, SE = .16, p < .001) and the ACR-C linear slope (β = -2.50, 
SE = .61, p < .001) were significant predictors. Thus, we reject the null hypothesis of 
these regression slope being equal to zero. As the SCS-SF intercept increased by 1 
standard deviation, the TRSI linear slope increased by .13 standard deviations. As the 
AAQ-II linear slope increased by 1 standard deviation, the TRSI linear slope increased by 
.40 standard deviations. As the ACR-C linear slope increased by 1 standard deviation, the 
TRSI linear slope decreased by .28 standard deviations. For reference, a full summary of 
hypothesis testing results can be found in Table 6.
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Table 6 
Hypothesis Testing Results 
Hypotheses 
Null Results 
(Reject or Fail to 
Reject the Null 
Hypothesis) 
Summary of Results 
H1 (PTSD Rate of Change Hypotheses)   
H1a (Self-Compassion) Reject 
1) First PCL-5 linear slope: The first SCS-SF linear slope (β = -1.58, SE = .13, p < .001) 
was a significant predictor. 
2) Second PCL-5 linear slope: The second SCS-SF linear slope (β = -1.60, SE = .21, p < 
.001) was a significant predictor. 
3) Third PCL-5 linear slope: The third SCS-SF linear slope (β = -1.81, SE = .61, p = .003) 
was a significant predictor 
H1b (Psychological Inflexibility) Fail to Reject The AAQ-II linear slope was not a significant predictor of any PCL-5 linear slopes 
H1c (Interpersonal Courage) Fail to Reject The ACR-C linear slope was not a significant predictor of any PCL-5 linear slopes 
H2 (Quality of Life Rate of Change   
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Hypotheses) 
H2a (Self-Compassion) Fail to Reject The SCS-SF linear slope was not a significant predictor of the Q-LES-Q linear slope 
H2b (Psychological Inflexibility) Reject 
The AAQ-II linear slope was a significant predictor of the Q-LES-Q linear slope (β 
= -1.00, SE = .20, p < .001) 
H2c (Interpersonal Courage) Fail to Reject The ACR-C linear slope was not a significant predictor of any PCL-5 linear slopes 




H3a (Self-Compassion) Fail to Reject The SCS-SF linear slope was not a significant predictor of the TRSI linear slope 
H3b (Psychological Inflexibility) Reject 
The AAQ-II linear slope was a significant predictor of the TRSI linear slope (β = .88, SE 
= .16, p < .001) 
H3c (Interpersonal Courage) Reject 
The ACR-C linear slope was a significant predictor of the TRSI linear slope (β = -2.50, 
SE = .61, p < .001) 




H4a (Self-Compassion) Reject 
1) First VLQ linear slope: The first SCS-SF linear slope (β = .62, SE = .15, p < .001) was a 
significant predictor. 
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2) Second VLQ linear slope: The second SCS-SF linear slope (β = .96, SE = .11, p < .001) 
was a significant predictor. 
3) Third VLQ linear slope: The third SCS-SF linear slope (β = .96, SE = .12, p < .001) was 
a significant predictor 
H4b (Psychological Inflexibility) 
Partially Reject (1st 
linear slope only) 
1) First VLQ linear slope: The AAQ-II linear slope (β = -1.49, SE = .60, p = .013) was a 
significant predictor. 
2) Second VLQ linear slope: The AAQ-II linear slope was not a significant predictor. 
3) Third VLQ linear slope: The AAQ-II linear slope was not a significant predictor. 
H4c (Interpersonal Courage) Fail to Reject The ACR-C linear slope was not a significant predictor of any VLQ linear slopes 
H5 (Treatment Completion Hypothesis) Reject Dropout rates did not vary based on the variables under study or demographic variables. 
H6 (Interpersonal Trauma vs. Non-
Interpersonal Trauma) 
Fail to reject 
Due to an extremely high rate of interpersonal (97%) vs. non-interpersonal (3%) trauma, 
comparative analyses between broad trauma categories was not feasible. 
H7 (Predictor of Discharge Scores Hypotheses)   
H7a (Admission Psychological 
Inflexibility Predicts Discharge PTSD 
symptom severity) 
Partially Reject 
1) Discharge PTSD Reexperiencing Factor: Admission psychological inflexibility (β = .38, 
SE = .11, p < .001) was a significant predictor. 
2) Discharge PTSD Avoidance Factor: Admission psychological inflexibility (β = .32, SE = 
.10, p = .002) was a significant predictor. 
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3) Discharge PTSD Negative Alterations Factor: Admission psychological inflexibility (β = 
.28, SE = .10, p = .006) was a significant predictor. 
4) Discharge PTSD Anhedonia Factor: Admission psychological inflexibility (β = .36, SE = 
.10, p < .001) was a significant predictor. 
5) Discharge PTSD Externalization Factor: Admission psychological inflexibility (β = .15, 
SE = .13, p = .195) not a significant predictor. 
6) Discharge PTSD Dysphoria Factor: Admission psychological inflexibility (β = .30, SE = 
.12, p = .012) was a significant predictor. 
7) Discharge PTSD Anxious Arousal Factor: Admission psychological inflexibility (β = 
.39, SE = .11, p < .001) was a significant predictor. 
H7b (Psychological Inflexibility Predicts 
Quality of Life) 
Reject 
Admission psychological inflexibility (β = -.17, SE = .10, p = .085) not a significant predictor of 
discharge quality of life. 
H7c (Self-Compassion Predicts Trauma-
related Shame) 
Fail to Reject 
1) Discharge Trauma-related Shame Internal Condemnation Factor: Admission positive 
self-compassion (β = .05, SE = .11, p = .694) and negative self-compassion (β = -.15, SE 
= .11, p = .194) were not significant predictors. 
2) Discharge Trauma-related Shame Internal Affective-behavioral Factor: Admission 
positive self-compassion (β = .15, SE = .11, p = .201) and negative self-compassion (β = 
-.17, SE = .12, p = .144) were not significant predictors. 
125
3) Discharge Trauma-related Shame External Condemnation Factor: Admission positive 
self-compassion (β = .05, SE = .11, p = .659) and negative self-compassion (β = -.06, SE 
= .11, p = .606) were not significant predictors. 
4) Discharge Trauma-related Shame External Affective-behavioral Factor. Admission 
positive self-compassion (β = .04, SE = .11, p = .718) and negative self-compassion (β = 
-.13, SE = .11, p = .256) were not significant predictors. 
H7d (Psychological Inflexibility Predicts 
Valued Living) 
Reject 
















Summary of Study Aims, Symptom Change, and Dropout 
 
As its main aim, this study explored how baseline scores and rates of change of self-
compassion, psychological inflexibility, and interpersonal courage predicted discharge scores 
and rates of change of PTSD symptom severity, quality of life, trauma-related shame, and valued 
living in participants who sought treatment at an exposure-based partial hospitalization program 
for PTSD. Several additional aims were undertaken. First, descriptive statistics were estimated to 
demonstrate symptom change over time. These results were further defined via the use of RCIs, 
which allowed us to determine if change in mean scores from admission to discharge was more 
than could be accounted for by measurement error. Next, this study attempted to assess how 
treatment completion might vary depending on trauma type (interpersonal vs. non-interpersonal). 
Finally, an intent-to-treat analysis was conducted to compare participants who completed at least 
two timepoints with participants who dropped out of treatment before the second timepoint on 
the measures on interest and demographic variables.  
A discharge latent regression model was estimated with a 7-factor model of discharge 
PTSD symptom severity, single factor model of discharge quality of life, single factor model of 
discharge valued living, and 4-factor model of discharge trauma-related shame discharge scores 
set as outcomes and a 2-factor model of admission self-compassion, single factor model of 
admission psychological inflexibility, and single factor model of admission interpersonal 
courage admission scores set as predictors. Race and gender were included in the model as 
covariates. 
127
With respect to latent growth curve models, the sheer number of analyses, in addition to 
the variable treatment length between participants, necessitated the estimation of four separate 
latent growth curve models to predict each outcome variable (i.e., PCL-5, Q-LES-Q-SF, TRSI, 
VLQ). Within these models, the variables that were assessed on a weekly basis (i.e., SCS-SF, 
PCL-5, VLQ) were found to be best represented by a three-piece spline curve, which estimated 
three separate linear growth curves based on identified points at which the slope of the data’s 
growth curve changed. Each of these models converged, which allowed for meaningful 
interpretation of model parameters. Unfortunately, due to an extremely high rate of interpersonal 
(97%) vs. non-interpersonal (3%) trauma, comparative analyses between broad trauma categories 
was not feasible. Subset analysis of trauma exposure (e.g., rape vs. physical assault) was also not 
possible due to participants experiencing a vast and varied trauma exposure history. As such, it is 
important to contextualize our findings as occurring within a population with wide-ranging 
trauma exposure, multiple comorbid conditions, and an almost universal experience of 
interpersonal trauma. 
Before discussing latent regression and latent growth curve model results, it is important 
to acknowledge the overall effect of treatment on the variables under study. From admission to 
discharge, participants experienced reliable change in the expected directions on all but one 
(Interpersonal Courage) of the variables under study. That is to say, beyond what might be 
accounted for by measurement error, PTSD symptoms decreased, trauma-related shame 
decreased, psychological inflexibility decreased, quality of life increased, valued living 
increased, and self-compassion increased. This shows that this treatment program is, according 
to the measures administered in the program, effective for those who complete it. Additionally, 
significant percentages of patients who completed treatment showed levels of PTSD symptom 
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severity, psychological inflexibility, and self-compassion comparable to those found in non-
clinical populations. For those who did not complete, the intent-to-treat analysis revealed small, 
yet statistically non-significant elevations in admission PTSD symptoms, trauma-related shame, 
and psychological inflexibility scores, as well as statistically non-significant deficits in self-
compassion, quality of life, valued living, and interpersonal courage. While the direction of these 
results was expected, the non-significant result suggests it is inappropriate to draw broad 
conclusions about dropout from the program based on measure elevations or deficits. 
Additionally, the intent-to-treat analysis found similar non-significant results with respect to 
demographic variables and dropout, which is likely due to the homogenous nature of the sample.  
A more statistically nuanced examination of dropout will likely be an important future study, 
though it is beyond the scope of the current project. However, based on the findings from this 
study, it appears that this exposure-based treatment program for PTSD (augmented with 
elements of ACT and DBT) is effective in reducing PTSD symptoms, trauma-related shame, and 
psychological inflexibility, while improving quality of life, valued living, and self-compassion.  
Summary of Latent Regression and Latent Growth Curve Results 
 
Latent Regression Results  
The estimated latent growth curve showed adequate model fit, which allowed for further 
interpretation of parameters. Admission psychological inflexibility was the only significant 
predictor for the discharge PTSD reexperiencing, avoidance, negative alterations (in cognition 
and mood), anhedonia, dysphoria, and anxious arousal factors. None of the tested predictors 
were significantly related to the discharge PTSD externalization factor. As will be discussed in 
the discussion section focused on latent growth curves, these results do not suggest that 
psychological inflexibility is the only important variable with respect to PTSD treatment, but 
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they do highlight the relative weight of psychological inflexibility upon admission to the 
program. Outside of externalizing behaviors, a wide range of elevated PTSD symptom clusters 
were predicted by admission psychological inflexibility, which suggests it is an essential 
construct to measure and address early in treatment.  
 While the robust findings with respect to admission psychological inflexibility and 
discharge PTSD symptom clusters are important to note, these findings do not apply to discharge 
trauma-related shame, quality of life, or valued living. No discharge trauma-related shame 
factors were related to the predictor variables, which is not consistent with findings from the 
literature (e.g., Au et al., 2017). One potential explanation for these findings might be 
extrapolated from the high prevalence of alexithymia in PTSD (Twohig, 2009) and the tendency 
for those with high levels of shame to struggle to engage with emotionally-laden content (Lanius 
et al., 2015). For patients who experience these internal experiences, emotionally-laden 
questions, such as those focused on self-compassion and shame, may skew admission assessment 
results. As such, the importance of the predictor variables with respect to trauma-related shame 
may be better understood by examining rates of change over time, as engagement in PTSD 
treatment can help alleviate alexithymia and improve patients’ abilities to engage with positive 
(e.g., self-compassion) and negative (e.g., shame) emotions (Lanius et al., 2015).  
 Finally, with respect to valued living, none of the predictor variables were significantly 
associated to valued living at discharge. While surprising at first glance, this finding is consistent 
with theoretical foundations of valued living. The concept of values-driven action may or may 
not be clear to patients upon entering treatment, though values clarification is a core component 
of treatment. For example, some patients may view entering treatment as a values-driven action, 
while other patients may have avoided considering their values as a function of their PTSD. For 
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these patients, an assessment focused on rating the importance of various values as well as the 
consistency with which they have pursued these values may result in a wide range of scores, 
depending on their interpretation and reaction to the questions. Values incongruence can be 
disturbing for patients (Wilson et al., 2010), which can then be discussed and addressed early in 
treatment. As such, mirroring the discussion concerning trauma-related shame, valued living is 
likely to grow and change over time, which might account for our null findings.  
Latent Growth Curve Results  
Four latent growth models were estimated to predict the within-person rate of change in 
PCL-5 scores (PTSD symptom severity), Q-LES-Q-SF scores (quality of life), TRSI scores 
(trauma-related shame), and VLQ scores (valued living). For each model, the intercepts and 
slopes of the SCS-SF (self-compassion), AAQ-II (psychological inflexibility), and ACR-C 
(interpersonal courage) were set as predictors. For the PCL-5, SCS-SF, and VLQ, three-piece 
splines models were estimated and retained after LRT comparisons to linear, quadratic, and 
cubic models. For all three spline models, the first two linear slopes were significant, yet the 
third linear slope was not. For the AAQ-II, ACR-C, Q-LES-Q-SF, and TRSI, linear models were 
retained after LRT comparisons to quadratic and cubic models.  
With respect to the latent growth models, contrary to our hypotheses, only the within-
person rate of change (increase) in self-compassion predicted the within-person rate of change 
(decrease) in PTSD symptom severity. This finding was consistent for the entire spline model. In 
other words, the first linear slope of the SCS-SF predicted the first linear slope of the PCL-5, the 
second linear slope of the SCS-SF predicted the second linear slope of the PCL-5, and the third 
linear slope of the SCS-SF predicted the third linear slope of the PCL-5. For valued living, all 
self-compassion linear slopes (increase) predicted all valued living linear slopes (increase), 
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mirroring the results for PTSD symptom severity. Interestingly, the within-person rate of change 
for psychological inflexibility predicted the first, but not the second or third linear slope of the 
valued living spline model. In contrast, only the within-person rate of change (decrease) in 
psychological inflexibility predicted the within-person rate of change (increase) in quality of life. 
Finally, for trauma-related shame, the within-person rates of change for both psychological 
inflexibility (increase) and interpersonal courage (decrease) predicted within-person rate of 
change over the course of treatment.  
The growth curve results, especially from the three-piece spline models, provide 
additional information concerning the time frames during which patients achieved the most 
significant symptom changes. For PTSD symptom severity, valued living, and self-compassion, 
the greatest symptom change occurred during the first six weeks of treatment. For valued living 
and self-compassion, the first week to two weeks of treatment resulted in little to no 
improvements, though these trends reversed dramatically in the next three to four weeks of 
programming. Treatment results from weeks 6 through 16 showed consistent, yet much more 
gradual symptom change on all three measures.  
Because the third linear slope within each spline model was non-significant, it is difficult 
to draw any conclusions concerning these results. This is likely because the typical length of stay 
in the program is approximately 12 weeks, and sample size decreases when approaching week 
16. However, an examination of plotted values allows for some tentative observations. After 
week 16, PTSD symptoms appeared to continue declining gradually, but self-compassion and 
valued living both increased at a steeper rate than was seen between week 6 and week 16. On the 
whole, while it is difficult to draw conclusions concerning the reasons behind these trends, it is 
possible that, with respect to PTSD symptoms, a high dose of treatment engagement (i.e., 6-7 hrs 
132
of programming per day) leads to near-immediate benefit that continues over the entire course of 
partial hospitalization programming. In exposure-based therapy for PTSD, substantial early gains 
have been linked to improved treatment outcomes and engagement (Doane, Feeny, & Zoellner, 
2010), which may help to explain our study’s similar dropout rate to those found in other 
exposure-based studies, despite the exceptional symptom severity and disorder comorbidity 
represented in the sample.  These early gains were then translated into gradual, consistent 
improvements in PTSD symptoms, self-compassion, and valued living over the rest of treatment. 
The late (after week 16) spikes in self-compassion and valued living are intriguing, as they do 
not coincide with a marked decrease in PTSD symptom reduction. One explanation for this 
pattern might be extrapolated from work by Schnurr and Lunney (2016), who found that the best 
predictor of quality of life improvements for people who engaged in exposure therapy for PTSD 
was the remission of the PTSD diagnosis. Based on these findings, as well as the reliable clinical 
change in PTSD symptoms and relatively large percentage of patients who discharged with PCL-
5 scores below the diagnostic cutoff score of 33, it may be that the late gains in self-compassion 
and valued living are representative of patients defining themselves beyond the context of their 
trauma and beginning to translate treatment gains into their everyday lives. This underscores the 
need for follow-up (e.g., after 2 months and 6 months) research to assess how this treatment 
impacted patients’ long-term wellbeing. It is important to note that these are tentative 
implications that cannot be tested within the scope of this project.  
In addition to our findings concerning the rate of change in our sample, several broad 
findings deserve mention. The surprising robustness of the effect of self-compassion is an 
important result, as is the confirmed strength of the relationships between baseline psychological 
inflexibility and our outcome variables. While we expected self-compassion and psychological 
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inflexibility to be strongly related to our outcome variables, the lack of effect from interpersonal 
courage was somewhat surprising. While the research literature supports the importance of 
interpersonal courage and connection in healing from trauma, it may be that strengthening 
psychological flexibility and self-compassion plays a more prominent role in successful 
treatment. The finding that the within-person rate of change in interpersonal courage predicted 
the within-person rate of change in trauma-related shame is encouraging, as interventions 
focused on trauma-related shame have emphasized the importance of sharing seemingly 
“broken” or “wrong” parts of themselves with trusted others (Lee et al., 2001). It should be noted 
that these assertions are tentative because the scale used to collect these data is new and its use 
has not been evaluated extensively to date. It is difficult to draw such construct-based 
conclusions from a new scale, as additional research using the measure is needed before making 
strong conclusions.  
Taken together, these findings suggest that psychological inflexibility, self-compassion, 
and interpersonal courage appear to be important in trauma-focused treatment, albeit in different 
ways. At the outset of treatment, psychological inflexibility provides valuable information 
concerning future treatment course with respect to symptom severity and pursuing a meaningful 
life defined beyond trauma. Over the course of treatment, self-compassion appears to play a 
prominent role in reducing PTSD symptom severity and pursuing valued living, while 
psychological inflexibility continues to be important with respect to change in quality of life and 
trauma-related shame. When working specifically with trauma-related shame, interpersonal 
courage also appears to play an important role. These results paint the picture of trauma 
treatment characterized by compassionate and flexible connections with the self and others while 
simultaneously engaging in evidence-based mechanisms of PTSD symptom reduction (i.e., 
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exposure). In the future, it appears the definition of evidence-based trauma treatment may well 
expand to include constructs such as the ones under study in this paper.  
Limitations 
 
 Although there are multiple strengths of this study, there are also several important 
limitations to discuss. The data analyzed in this study were obtained from a clinical treatment 
program, and as such, there was no control group. This limits our ability to make causal 
inferences about the impact of various treatment elements (e.g., PE vs. DBT vs. ACT) and to 
formally assess treatment fidelity or consistency across program sites. Another limitation related 
to the clinical setting is the near-exclusive use of self-report instruments without a measure of 
malingering, which may bias our findings. It should be noted that completing an evidence-based 
treatment is a strong recommendation for patients who may be pursuing a PTSD diagnosis for 
secondary gain, so our analytic approach of only including participants with at least two primary 
timepoints has been empirically shown to be a strong (yet, incomplete) safeguard against biased 
results (Hall & Hall, 2007; Marx et al., 2012). In terms of the generalizability of this study, our 
results were obtained in a PTSD partial hospitalization with largely White and female patients 
who indicated severe levels of symptom severity and comorbidity. As such, results may not be 
generalizable to PTSD treatment delivered in a weekly outpatient format, trauma-exposed 
samples with less severe symptomatology, or more demographically diverse samples.  
In terms of analysis, while this study benefits from the use of longitudinal analysis using 
multiple timepoints, the asymmetry between the analyzed timepoints is an additional limitation. 
Ideally, all measures would contain the same number of timepoints to assess growth over the 
exact same amount of time. Because this study utilized data from a clinical sample, treatment 
duration varied between patients. Additionally, the combination of the spline models calculated 
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for weekly measures and the single linear models calculated for the non-weekly measures may 
have resulted in a loss of specificity in analysis. While this does not prevent us from drawing 
inferences from these data, future studies would likely benefit from confirming our results using 
both controlled studies and symmetrical data points for each growth curve.   
Suggestions for Future Research, Practice, and Policy 
 
 The limitations of this study provide several concrete directions for future research. 
While our findings are encouraging, they should be replicated in more diverse samples. Future 
controlled replication attempts might also utilize component analyses to assess which elements 
of treatment (i.e., PE vs. DBT vs. ACT) significantly contribute to change in the variables under 
study. Statistically, future analyses would benefit from more consistency in data points available 
for growth curve analysis.  
 This study’s implications for future practice are particularly intriguing. Because this 
study assessed rate of change over time using multiple timepoints, we are able to make several 
cautious assertions about implications for treatment. Given our findings concerning the 
importance of both self-compassion and psychological inflexibility in evidence-based trauma 
treatment, recommendations for future practice are partially in line with existing 
recommendations and partially novel. The finding that within-person rate of change in 
psychological inflexibility is a significant predictor of quality of life and trauma-related shame 
shows the importance of actively targeting this construct in PTSD treatment, especially when 
considering outcomes beyond symptom reduction. This is, in many ways, in line with current 
and evolving directions in evidence-based PTSD treatment. The inhibitory learning model of 
exposure (Craske, Treanor, Conway, Zbozinek, & Vervliet, 2014) has gained momentum in 
recent years as a method of maximizing exposure therapy across multiple disorders, including 
136
PTSD (Lebois, Seligowski, Wolff, Hill, & Ressler, 2019). Several recommendations from the 
inhibitory learning model that overlap with the psychological flexibility model include 
expectancy violation, variability in exposure, contextual variation, and affect labeling. Our 
findings suggest the importance of not only measuring psychological inflexibility at the 
beginning of treatment, but also working to integrate flexibility into exposure-based treatment.  
 A relatively novel recommendation that can be gleaned from our findings is the 
integration of compassion-focused elements into evidence-based PTSD treatment. While other 
studies (e.g., Dahm et al., 2015; Hiraoka et al., 2015) have provided preliminary results 
suggesting the importance of self-compassion in PTSD treatment, this is, to our knowledge, the 
first study to have assessed the impact of change in self-compassion in a treatment-seeking 
PTSD population. Previous research from Grau, Larsen, Lancaster, Garnier-Villarreal, and 
Wetterneck (in press) has demonstrated the importance of cultivating an expansive sense of self 
in PTSD treatment, and the results from this study help to clarify that expansion. This study 
suggests that the process of developing a sense of self that is characterized by mindful 
awareness, a sense of connection with others, and compassionate engagement with difficult 
experiences is predictive of decreases in PTSD symptoms and increases in the pursuit of 
meaning and values. Traditionally, PTSD treatments do not explicitly target self-compassion (Au 
et al., 2017). Given the findings from this study, one way to increase the efficacy of PTSD 
treatment might be to build in exercises designed to cultivate compassion such as compassionate 
imagery or compassion-focused meditation (Gilbert, 2010).  
 On a broader scale, our results support the assertions from Cloitre (2015) and other 
researchers focused on complex and repeated interpersonal trauma: PTSD treatment should 
expand beyond a singular focus on symptom reduction. The inclusion of non-symptom-focused 
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measures in this study allowed for a more nuanced understanding of the processes of change 
over time in PTSD treatment. That we failed to reject several hypotheses demonstrates the 
limitations of the current research base for PTSD treatment, especially with respect to constructs 
that are not traditionally assessed for in PTSD trials (e.g., self-compassion, valued living). While 
we did find evidence in support of recent advances in exposure therapy, there is also a need to 
explore programmatic shifts to incorporate compassion-based interventions in trauma-focused 
treatment. Based on these results, policy makers might consider supporting funding for 
augmented PTSD treatments to further explore ways in which evidence-based PTSD 
interventions might be improved. Additionally, our results would not have been possible without 
the implementation of a thorough, measurement-based approach to clinical research. This is 
additional evidence in support of systematic collection of data in treatment programs. As was 
shown in this paper, clinical outcomes research presents a unique opportunity to provide novel 
information concerning change over time, and policymakers would do well to allocate support 
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